Engineering Enzyme Colocalization Within The Cytoplasm Of Escherichia Coli by Conrado, Robert
 ENGINEERING ENZYME COLOCALIZATION WITHIN THE CYTOPLASM
OF ESCHERICHIA COLI
by Robert John Conrado 
This thesis/dissertation document has been electronically approved by the following individuals:
Delisa,Matthew (Chairperson)
Wilson,David B (Minor Member)
Varner,Jeffrey D. (Minor Member)
  
 
ENGINEERING ENZYME COLOCALIZATION WITHIN THE CYTOPLASM OF 
ESCHERICHIA COLI 
 
 
 
 
 
 
 
 
A Dissertation 
Presented to the Faculty of the Graduate School 
of Cornell University 
In Partial Fulfillment of the Requirements for the Degree of 
Doctor of Philosophy 
 
 
 
 
 
 
by 
Robert John Conrado 
August 2010
  
 
 
 
 
 
 
 
 
 
 
 
© 2010 Robert John Conrado
  
ENGINEERING ENZYME COLOCALIZATION WITHIN THE CYTOPLASM OF 
ESCHERICHIA COLI 
 
Robert John Conrado, Ph. D. 
Cornell University 2010 
 
There is ever increasing interest in developing biological routes for the production of 
valuable chemicals, especially for those products whose current manufacture is from 
non-renewable resources or whose synthesis has proven difficult or intractable using 
traditional synthetic routes. One common approach to this problem is to harness the 
synthetic potential of living cells that carry engineered metabolic pathways. However, 
even after a functional biosynthetic pathway is created in a metabolically engineered 
microorganism such as Escherichia coli, many bottlenecks can ensue including (i) 
diverted metabolic flux away from the desired product, and (ii) accumulation of toxic 
intermediates that can inhibit host cell growth. This work reviews the entire history of 
engineered colocalized enzymes, both in vitro and in vivo, and posits the necessary 
components for successful engineered systems. Next, a stochastic multidimensional 
model was developed to study the impact of enzyme compartmentalization to measure 
the effect of increased local concentrations versus substrate diffusivity. As a first step 
to engineer these systems in vivo, fusion proteins and various post translational 
interactions were employed to improve the production of both 1,2-propanediol and 
1,2,4-butanetriol in E. coli. The difficulty in resolving true synergy indicated the 
importance of independent colocalization techniques that would provide better 
engineering controls and permit multiple parameters for further optimization. In 
response, DNA scaffolds were developed to colocalize a series of sequential reactions 
 along a plasmid DNA surface. This was accomplished for both 1,2-propanediol and 
mevalonate production in E. coli and resulted in 5-fold and 4-fold increases 
respectively. Future work is needed to further optimize these systems and understand 
the inherent complexity of coupled, multimeric enzymes. The use of synthetic DNA 
scaffolds in vivo provides a powerful new methodology that can be used alongside 
conventional engineering methods. In the long term, the possibility of integrating 
several of these strategies simultaneously to balance pathway flux, eliminate metabolic 
bottlenecks, reduce cell stress, and prevent accumulation of unwanted intermediates 
and/or byproducts could pave the way to produce commercially viable levels of 
diverse metabolic products such as biofuels, specialty chemicals and therapeutics. 
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CHAPTER 1 
 
ENGINEERING THE SPATIAL ORGANIZATION OF METABOLIC ENZYMES
1
 
 
Introduction 
Many years of engineering microorganisms have provided scientists with an 
expansive toolkit for the production of a vast array of valuable compounds, including 
commodity and specialty chemicals (e.g., biodegradable plastics), biofuels (e.g., 
ethanol, butanol), and therapeutic molecules (e.g., anticancer drugs, antimicrobial 
compounds). Since these products can be derived from renewable feedstocks, there is 
increasing interest in developing and optimizing biological routes for their production, 
especially for complex molecules whose manufacture has proven difficult or 
intractable using traditional synthetic routes. While numerous opportunities exist for 
biochemical conversion using natural and engineered microorganisms, a large number 
of metabolic reactions are characterized by low productivity and yield [1], as well as 
by undesirable side reactions [2]. Overcoming these issues presents a formidable 
challenge for the following reasons: first, metabolic intermediates are often unstable or 
toxic [3]; second, native and especially non-native enzymes can have low substrate 
specificity [2]; and third, competing reactions are frequently required or ill-defined 
[2]. Thus, when considering the use of microorganisms for chemical manufacture, 
several key questions arise such as: (1) how many metabolic processes would be 
economically viable if product titers were increased; and (2) are there techniques 
available that provide a simple, generic framework for increasing productivity of the 
desired product while reducing the formation of unwanted byproducts? In searching 
                                                 
1
 Adapted with permission from: Conrado RJ, Varner JD, DeLisa MP (2008) Engineering the spatial 
organization of metabolic enzymes: mimicking nature‘s synergy. Curr Opin Biotechnol 5:492-9 and 
DeLisa MP and Conrado RJ (2009) Synthetic metabolic pipelines. Nat Biotechnol 8:728-9. 
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for the answers to these questions, it is important to consider how natural biological 
systems employ spatial organization of metabolic enzymes as a strategy to overcome 
barriers to metabolite production. From an understanding of this organization, new 
strategies for efficiently assembling metabolic enzymes into structures that yield high 
product titers can be developed that will effectively expand the metabolic engineering 
toolkit. 
Naturally occurring metabolic channels 
In stark contrast to the dilute solutions in which classical enzymology studies 
are conducted, the interior of cells is a highly volume-occupied physico-chemical 
environment with macromolecules comprising ~20-30% of the cytoplasmic volume of 
Escherichia coli [4]. This high concentration of macromolecules results in crowding 
conditions that can have a profound effect on the structure, function, and evolution of 
biological processes. For instance, crowding can drastically alter equilibrium and 
biochemical rate constants and can impose increased tortuosity on molecular motion. 
As a result, small molecule diffusion measured in cells is 3-4-fold slower than in pure 
water and this effect dramatically increases for proteins of high molecular weight 
[5,6]. Crowding is also known to exert a generalized pressure for the reduction of the 
surface to volume ratio that drives the formation of well-defined oligomeric 
complexes via specific associations [4]. There are also a number of kinetic benefits [7] 
that have provided an evolutionary driving force towards multifunctional enzyme 
systems that couple enzyme reactions for sequential conversion steps, a process 
commonly referred to as metabolic channeling [8,9]. One of the most immediate 
consequences of metabolic channeling is that enzyme active sites for consecutive 
reactions are brought into close proximity, which reduces the intermediate diffusion 
distance and therefore increases the probability that a metabolic intermediate 
undergoes a sequential reaction step before diffusing away. This serves to increase the 
 3 
catalytic efficiency for channeled substrates by 1-2 orders of magnitude as observed 
for the Salmonella typhimurium tryptophan synthase channel [10]. In addition, 
metabolic channels relieve cellular constraints as they maintain high local 
concentrations while keeping total cellular levels low, which is especially important 
for toxic or unstable intermediates [8,11,12]. Lastly, multifunctional enzyme systems 
enable metabolic control by regulating the assembly of enzymes that act on multiple 
substrates and preventing metabolic cross-talk between competing pathways [13]. In a 
remarkable example of metabolic control, Benkovic and coworkers observed that all 
six enzymes needed for purine biosynthesis colocalized to form clusters in the 
cytoplasm of HeLa cells termed ―purinosomes‖ [14]. Unexpectedly, the enyzmes 
associated when cells were depleted of purine but dissociated when the demand for 
purine was low, providing clear evidence for dynamic regulation of metabolism at the 
level of post-translational assembly of enzymes into multifunctional complexes. 
Natural multifunctional enzyme systems have been discovered in both primary 
and secondary metabolism and span a wide range of organisms. In the case of primary 
metabolic pathways, channeling has been observed in central carbon metabolism [15], 
fatty acid oxidation [16], the Calvin cycle [17], amino acid biosynthesis [18], the 
carboxysome [19], and the proteasome [20]. One notable example of channeling is 
seen for tryptophan biosynthesis, which is mediated by the polyaromatic pathway that 
is comprised of 13 total enzyme reactions, 7 of which constitute the polyaromatic 
branch. In fungi, this pathway includes a multifunctional enzyme known as the 
AROM complex that has evolved to link five distinct enzymatic activities into a single 
polypeptide (Figure 1.1A). The AROM complex is encoded by a continuous 4,812-bp 
open reading-frame without introns that is believed to have arisen by multiple gene 
fusions [9]. The output of this locus is a single mRNA transcript that specifies a 
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Figure 1.1. Nature‘s solutions to enzyme colocalization. (A) Fungal AROM complex 
with the five active sites labeled on this single polypeptide chain (adapted from [18]); 
(B) Tryptophan synthase  complex showing the physical tunnel channeling the 
indole intermediate (adapted from [10]); (C) Dhurrin synthesis from a multifunctional 
enzyme complex where arrows indicate a reaction step; (D) Model of phenylpropanoid 
metabolism in plants where several endoplasmic reticulum membrane bound enzymes 
allow multienzyme complex assembly for metabolite transfer between sequential 
reaction steps. Key branch points exist resulting from a common set of intermediates 
between the specific phenylpropanoid pathways (adapted from [21]). 
pentafunctional polypeptide catalyzing five consecutive steps leading to the 
production of 5-enolpyruvylshikimate 3-phosphate in the shikimate pathway [18,22]. 
Interestingly, the same enzymatic activity in prokaryotes arises from five unlinked and 
monofunctional enzymes [23]. Evidence that the five active sites of the AROM protein 
behave as a coordinated multienzyme system come from kinetic studies in which 
higher catalytic activity and lower Km values were observed for the individual catalytic 
sites within wild type complexes over complexes with mutations to residues in a single 
active site [18]. In addition to the AROM protein, the polyaromatic pathway also 
includes the tryptophan synthase complex, which catalyzes two sequential reactions to 
produce tryptophan (Figure 1.1B). Tryptophan synthase, an a2b2 complex, is thought 
to channel the metabolic intermediate indole from the active site of the a subunit to the 
active site of the b subunit. Channeling is conferred by a physical tunnel, with a 
diameter matching that of indole, that connects the adjacent active sites and prevents 
indole from diffusing into the bulk [10,24]. This mode of substrate channeling 
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effectively prevents indole from freely diffusing out of the cell and increases the 
reaction rates by 1-2 orders of magnitude over the free, uncomplexed subunits [10,25].  
In contrast to the high-affinity protein interactions typical of the tryptophan 
biosynthetic machinery, channeling in secondary metabolism is often characterized by 
dynamic, low-affinity enzyme interactions such as has been observed for modular 
multifunctional polyketide synthases in bacteria [26]. Similarly, a plethora of studies 
in plants have demonstrated a role for metabolic channeling and colocalization in the 
formation of numerous secondary products [7], including the biosynthesis of 
isoprenoids [27], alkaloids [28], flavonoids [29], cyanogenic glucosides [11] (Figure 
1.1C), and phenylpropanoids [30] (Figure 1.1D). Cyanogenic glucosides such as 
dhurrin represent a class of plant secondary compounds produced via a multienzyme 
system for protection against herbivores. In Sorghum bicolor, 7 catalytic steps yield 
dhurrin from L-tyrosine, but only 3 membrane-bound enzymes are required for this 
biotransformation [31] (Figure 1.1C). According to the proposed reaction mechanism, 
the first two enzymes of this system, CYP79A1 and CYP71E1, are both 
multifunctional, catalyzing 4 and 2 reactions respectively when expressed 
endogenously in S. bicolor and in recombinant E. coli [32]. As further evidence of 
channeling in this system, radioactive labeling experiments demonstrated that dhurrin 
production primarily came from L-tyrosine, even in the presence of saturating 
intermediates [33]. However, the channeling properties of this system were not fully 
appreciated until the S. bicolor 3-enzyme pathway was introduced into Arabidopsis 
thaliana [11]. In the engineered plant lines carrying only the first 2 enzymes for 
dhurrin biosynthesis, a stunted phenotype resulted from accumulation of the toxic 
intermediate, p-hydroxymandelonitrile. When the third enzyme of the dhurrin pathway 
was introduced into these transgenic plants, the normal growth phenotype was 
restored, dhurrin accumulated up to 4% by dry weight, and toxic byproducts were no 
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longer detectable within the plant material [11]. These dramatic results provide 
compelling evidence for the efficient coupling between the individual enzymes in 
dhurrin biosynthesis. 
Engineering Multifunctional Enzyme Systems 
The intentional engineering of metabolic pathways is a rapidly maturing field 
and much attention has already been given to cellular productivity and diverted flux. 
Indeed, a number of strategies have been reported for optimizing cellular metabolism 
including, for example, stabilizing mRNA transcript levels, balancing protein 
expression levels, evolving enzyme activity, and redirecting cellular metabolism [34]. 
These successes notwithstanding, very little attention has been given to the spatial 
organization of the recombinant metabolic pathway enzymes in vivo. Yet, based on 
numerous examples from nature (see above), it is clear that enzyme organization is a 
key design variable to be considered when engineering metabolism, as exemplified by 
the studies described below. 
Immobilized Enzyme Systems. One approach to engineering multienzyme systems 
that mimic those found in nature is via immobilized enzymes whereby sequential 
chemical conversions are performed by tethering pathway enzymes on polymer 
particles (Figure 1.2A). In one notable example, a 140% increase in product formation 
was reported in comparison to the free enzyme system [35]. A similar effect has been 
observed for several two- and three-enzyme systems, either by immobilization 
[36,37,38] or chemical crosslinking of the enzymes [38]. While immobilized enzyme 
systems provide evidence that sequential pathway enzymes can be spatially organized 
to achieve kinetic benefits, the approach is often limited by the technical difficulty and 
cost associated with scale-up of cell-free systems. Thus, techniques for organizing 
enzymes inside of living cells would be preferable owing to the ease with which cell-
based systems can be manipulated and scaled-up. 
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Figure 1.2. Engineering opportunities for enzyme colocalization. (A) Immobilized 
enzymes on a solid support. (B) Fusion proteins connected by a peptide linker. (C) 
Post-translational assembly of enzyme complexes where CBD represents the cellulose 
binding domain, C1-C3 represent cohesin domains, and D1-D3 represent dockerin 
domains (adapted from [39]). 
Fusion Proteins. An alternative approach to artificial bifunctional and multifunctional 
enzymes is the creation of chimeric proteins whereby two or more distant genetic 
elements are combined by a short linker sequence to yield a single polypeptide that 
exhibits more than one activity (Figure 1.2B). For example, Mosbach and coworkers 
engineered an in-frame fusion between the structural gene for E. coli beta-
galactosidase (LacZ), a tetrameric enzyme, and the gene encoding E. coli 
galactokinase (GalK), a monomeric enzyme, for the two-step conversion of lactose to 
galactose-1-phosphate. The resulting fusion protein displayed the enzymatic activity 
of both gene products, albeit with significantly reduced individual activities [40]. 
Shortly thereafter, the same group created an in-frame fusion between LacZ and the 
dimeric galactose dehydrogenase (GalDH) from Pseudomonas fluorescens for the 
sequential hydrolysis of lactose followed by the oxidation of the galactose, forming 
the corresponding lactone [41]. In this instance, the bifunctional enzyme displayed 
kinetic advantages (e.g., exhibited a 2-fold reduction in the saturation constant, Km, for 
lactose and reached steady state 2-4 fold faster in solution) over the identical native 
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system in conversion of lactose to galactonolactone especially at low substrate 
concentrations. This suggests that the proximity conferred by the artificial fusion 
enabled some amount of synergistic coupling of the sequential reactions (i.e., substrate 
channeling) that was absent when the enzyme activities were distinct. Such an effect 
has been seen with other bifunctional and, in some cases multifunctional, enzyme 
systems (summarized in Table 1.1) as well as with immobilized enzyme systems 
above. It should be pointed out, however, that the notion of channeling for 
bifunctional enzyme fusions has not progressed without some controversy. For 
instance, Pettersson and coworkers developed an alternative analysis approach 
whereby inferences about the rate behavior of a fusion protein were drawn from the 
altered kinetic properties of the fusion protein itself [42,43], which they argued was 
more reliable than the analysis methods used previously. These authors found no 
tenable kinetic evidence to support the earlier claim [41] that the LacZ-GalDH fusion 
protein catalyses galactonolactone formation from lactose by a mechanism involving 
channeling of galactose [42]. Thus, care needs to be taken when evaluating the effect 
of enzyme fusion proteins on metabolic conversions. 
In order to mimic the crowding and higher viscosity of the cytoplasm under in 
vitro conditions, crowding agents such as poly(ethylene glycol) have been added to the 
enzyme reactions to increase the viscosity and slow molecular diffusion [44,45]. For 
instance, when the in vitro viscosity was raised to 8 times that of water, the coupled 
enzyme activity of a choline dehydrogenase (CDH)/betaine aldehyde dehydrogenase 
(BADH) fusion protein increased by over 120% while the activity of the free enzyme 
system increased only 45%. Importantly, the activity of the BADH enzyme remained 
constant when studied in isolation, despite the increase in the viscosity of solution 
[60]. These studies suggest that the benefit of enzyme fusions may be even greater in
9 
Table 1.1: Engineered Pathway Colocalization and Degree of Synergistic Effect 
(DSE) 
Pathway Method Enzymes 
(Organism) 
Assay 
Environ-
ment
1
 
DSE
2
 Ref. 
Glycerol 
Production 
Fusion GPD1, GPP2  
(S. cerevisiae) 
In vivo  
(E. coli) 
In vitro  
2 
 
2 
[8] 
Poly 
(hydroxybutyrate) 
(PHB) production 
Fusion PhaA, PhaB  
(R. eutropha) 
In vivo  
(E. coli)  
In vivo  
(A. thaliana) 
0.2 
 
0.7 
[46] 
Starch hydrolysis Fusion CelY, CelZ (C. 
stercorarium) 
In vitro  1.9-3.5 [47] 
 Fusion -amylase, 
glucoamylase  
(A. shirousamii) 
In vitro  2.5 [48] 
Glucose 
phosphotransferase 
Fusion IICB
Glc
, IIA
Glc
, 
HPR, I (E. coli) 
In vitro  3-4 [49] 
Trehalose 
synthesis 
Fusion TPS, TPP  
(E. coli) 
BvMTS, 
BvMTH  
(B. helvolum) 
In vitro  3.5-4.0 
1.0-1.3 
[50] 
[51] 
 Fusion TDFE, TFE  
(S. solfataricus 
MT4) 
In vitro  2.6 [52] 
 Fusion BA (C. thermo- 
sulfurogenes), 
TS (T. 
thermophilus) 
In vitro  1.2-1.4 [53] 
Formaldehyde 
fixation 
Fusion HPS, PHI (M. 
gastri MB19) 
In vitro  2 [54] 
NADH recycling Fusion LDH (B. 
stearothermophil
us), GalDH  
(P. fluorescens) 
In vitro  2 [44] 
Ferulic acid 
release 
Fusion FAEA, XYNB 
(A. niger) 
In vitro  1.3-2.0 [55] 
Cellulose 
hydrolysis 
Scaffoldin CelA, CelG (C. 
cellulolyticum) 
In vitro 2.1-2.6 
2 
[56] 
[57] 
Mevalonate Protein 
Scaffold 
AtoB (E. coli), 
HMGS, HMGR 
(S. cerevisiae) 
In vivo 
(E. coli) 
77 [58] 
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Table 1.1: Engineered Pathway Colocalization and Degree of Synergistic Effect 
(DSE) cont. 
Pathway Method Enzymes 
(Organism) 
Assay 
Environ-
ment
1
 
DSE
2
 Ref. 
Glucaric Acid Protein 
Scaffold 
Ino1 (S. 
cerevisiae), 
MIOX (M. 
musculus), Udh 
(P. syringae) 
In vivo 
(E. coli) 
In vivo 
(E. coli) 
3 
 
5 
 
[58] 
[59] 
1
For in vivo studies, host organism is given in parenthesis. 
2
DSE is measured as the fold improvement in the enzyme compartment activity or flux 
compared with the equimolar free enzyme system, where a value of 1.0 means no 
difference. 
vivo, as the molecular crowding of the cell may further enhance the advantages seen in 
vitro. Interestingly, in vitro studies on purified fusion proteins typically report a lower 
specific activity, as low as 20% of the individual enzyme activities that make up the 
fusion [50,53,61], yet despite this the bifunctional enzyme often outperforms its free 
enzyme counterpart due to the effect of channeled enzyme kinetics [8]. 
While the kinetic properties of bifunctional and multifunctional enzymes offer 
several advantages that might be useful in metabolically engineered cells, most of 
these systems have not been systematically evaluated in vivo. In fact, there have only 
been a few reported cases exploring the utility of enzyme fusions for enhancing multi-
step metabolic reactions inside living cells. One noteworthy example was reported by 
Soucaille and coworkers who sought to engineer a Saccharomyces cerevisiae glycerol 
pathway in E. coli via a traditional strain engineering approach [8] (see Table 1.1). E. 
coli cells transformed with a plasmid for the separate expression of the S. cerevisiase 
glycerol pathway enzymes GPD1 and GPP2 were grown in a chemostat and after 
several days a high glycerol producer was isolated. Serendipitously, the evolved strain 
carried a plasmid in which a deletion event had occurred between GPD1 and GPP2, 
creating an in-frame fusion protein containing both glycerol-3-P dehydrogenase and 
glycerol-3-P phosphatase activities. Fed-batch cultivation of E. coli cells expressing 
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this fusion exhibited a 2-fold improvement in glycerol biosynthesis. Consistent with 
this intracellular enhancement, the purified fusion displayed measurable kinetic 
improvements including a 7-fold reduced transient time, 5-fold reduced metabolite 
intermediate concentration, and a 2-fold increased production rate when studied under 
steady-state kinetics, which the authors ascribed to partial glycerol-3-P channeling 
between the two active sites [8]. This rather remarkable result provides support for the 
hypothesis that multifunctional enzymes in nature arose from gene fusions and that 
spatial organization of recombinant metabolic pathways can be intentionally designed 
to exhibit similar synergistic activity. 
Along similar lines, Snell and coworkers explored enzyme fusions for 
enhancing bacterial and plant-based biosynthesis of polyhydroxybutyrate (PHB) 
granules by expressing a fusion between the Ralstonia eutropha thiolase (PhaA) and 
reductase (PhaB) enzymes in E. coli and separately in Arabidopsis [46]. A PhaA-PhaB 
fusion protein library, in which the linker sequence length and composition were 
randomized, was screened in E. coli and the highest polymer-producing clone had 
significantly reduced enzymes activities, indicating that a fusion was not well tolerated 
between these naturally homotetrameric enzymes (see Table 1.1). When the construct 
was transformed into Arabidopsis, the fusion performed better relative to the E. coli 
system but still underperformed relative to the free enzymes (see Table 1.1) due to 
problems with folding and solubility that adversely affected the enzyme activity [46]. 
 The above examples underscore some of the key challenges associated with 
enzyme fusions. First, the fact that many metabolic enzymes are multimeric presents 
an assembly conundrum (Figure 1.3). That is, while a fusion of two normally 
monomeric enzymes is straightforward. Fusion of two normally multimeric enzymes 
requires subunit assembly for activity. These higher-ordered structures can interfere 
with the non-covalent interactions that are required for the activity of individual  
12 
 
Figure 1.3. Complexes of multimeric fusion proteins. Tertiary and quaternary 
structures of a protein fusion between (A) two monomers, (B) a monomer and a 
tetramer, (C) a dimer and a tetramer, forming a multimeric protein aggregate in this 
last case (adapted from [62]). 
enzyme subunits and can lead to a partial protein network that may or may not exhibit 
enzymatic activity. Along these lines, the LacZ-GalDH fusion yielded two major 
forms, consisting of four and six subunits, but other forms could also be identified and 
were characterized as aggregated material [41]. Second, folding of large multidomain 
proteins is typically inefficient in bacteria [63,64], thus numerous enzyme fusions may 
misfold or aggregate when expressed in bacteria. Indeed, this was the case for the 
LacZ-GalK fusion, which formed insoluble aggregates following in vivo expression 
[40].  
Post-Translational Assembly. As an alternative to protein fusions, recent work has 
explored the use of post-translational assembly mechanisms for linking individual 
enzymes that then act coordinately on sequential reaction steps. The first-documented 
example is based on natural cellulosomes [56] (Figure 1.2C), complex 
macromolecular assembles that efficiently degrade cellulose and plant cell walls. The 
engineered complexes are composed of two main parts derived from natural 
cellulosomes:  (1) the scaffoldin, containing a cellulose-binding domain (CBD) and 
several cohesin binding domains on a single polypeptide; and (2) the enzyme-dockerin 
fusion that binds to the scaffoldin post-translationally by means of a high-affinity 
dockerin-cohesin interaction [39,57,65]. Using the CBDs, cohesins, and dockerins as 
building blocks, Fierobe and colleagues created designer cellulosomes in which 
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selected enzymes were incorporated in specific locations within a multicomponent 
complex by means of high-affinity cohesin-dockerin interactions [39]. Using this 
strategy, the Clostridium cellulolyticum cellulosomal family-5 CelA and family-48 
CelF cellulases were each fused to dockerins and the resulting fusions were assembled 
precisely and by design onto a scaffoldin backbone. Compared with the mixture of 
free cellulases, the resultant cellulosome chimeras exhibited enhanced synergistic 
action on crystalline cellulose. These same authors went on to construct a library of 75 
different chimeric cellulosomes and identified complexes that conferred a 1.1-7.2-fold 
enhancement over free enzymes in the ability to degrade cellulose and a 2-fold 
enhancement resulted from the synergy when sequential enzymes were brought into 
close proximity on the cellulose substrate [57] (Table 1.1). Within this framework, a 
variety of geometries and enzyme arrangements have been explored with varying 
amounts of success [65], indicating that geometry may play an important role in 
enzyme colocalization, at least in the case of recombinant cellulosomes.  
Recently, Dueber et al. [58] created intracellular protein scaffolds (pipelines) 
to which successive pathway enzymes can dock by means of small peptide ligands. 
The scaffolds contained multiple highly specific and modular docking domains from 
metazoan genomes: the GTPase binding domain (GBD) from the actin polymerization 
switch NWASP, the SH3 domain from the adaptor protein CRK, and the PDZ domain 
from the adaptor protein syntrophin. Three metabolic enzymes for mevalonate 
production—E. coli AtoB and Saccharomyces cerevisiae HMGS and HMGR—were 
targeted to the scaffold using specific ligands corresponding to each docking domain, 
a strategy reminiscent of the modular domain framework recently used to build 
ultrasensitive signaling switches [66]. 
The advantage of this strategy for enzyme assembly is that these ligands are 
much smaller than the dockerin domains employed above and in Figure 1.2C. By 
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noncovalently tethering the enzymes to the synthetic scaffold, Dueber et al. [58] 
showed that mevalonate yields could be increased by as much as 77-fold compared 
with the unscaffolded pathway, depending on both the number of interaction domain 
repeats and the domain orientation in the scaffold architecture. The same 
programmable scaffolds were then used to enhance the production of a structurally 
unrelated compound, glucaric acid, indicating that this approach might be extended to 
other metabolic pathways.  
It appears that post-translational assembly of individual enzymes may 
overcome the issues of solubility, folding, and macromolecular complex assembly, 
and it has been successfully applied in vivo and in vitro. However, the fundamental 
reasons behind this increased yield of mevalonate remain mysterious, as it is difficult 
to decouple protein stability from activity, and the stability of the protein scaffold 
remains an important question. Regardless, the use of synthetic enzyme scaffolds can 
clearly improve metabolic performance and provides a powerful new method that can 
be used alongside conventional methods. In the long term, the possibility of 
integrating several of these strategies simultaneously to balance pathway flux, 
eliminate metabolic bottlenecks, reduce cell stress, and prevent accumulation of 
unwanted intermediates or by-products is limited only by one's imagination and 
should clear the way to produce commercially viable levels of diverse metabolic 
products such as biofuels, specialty chemicals and therapeutics.  
Recent developments engineering enzyme colocalization 
In this work, we present a progression of engineering enzyme colocalization in 
the cytoplasm of E. coli toward R-1,2-propanediol (1,2-PD) first, and later D-1,2,4-
butanetriol (1,2,4-BT) and mevalonate. First, we develop a kinetic model of 1,2-PD 
diffusion-reaction kinetics using a 3-D stochastic algorithm that allows us to study 
coupled reaction kinetics under enzyme compartmentalization. Second, we 
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systematically evaluate the efficacy of fusion proteins with an array of proteins and 
peptide linkers within the 1,2-PD biosynthetic pathway. This represents an application 
of the current state of the art and provides motivation in moving towards more 
complex systems. Then, we apply well-known protein-interacting domains (PIDs) to 
assemble enzymes, allowing proteins to fold independently. The novel application of a 
leucine zipper to drive interactions of metabolic enzymes (both towards 1,2-PD and 
1,2,4-BT) shows the benefits of post-translational assembly and highlights the 
importance of balancing flux within the context of a channeled biosynthetic pathway. 
We briefly test the protein scaffolds employed by Dueber et al. [58]. Finally we 
develop stable and modular DNA scaffolds with the use of DNA binding domains. In 
this manner, we generated a robust set of DNA scaffolds for tethering metabolic 
enzymes in a way that both balances flux as well as maximizes site occupancy, 
allowing us to improve the yield towards both 1,2-PD and mevalonate.  
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CHAPTER 2 
 
STOCHASTIC REACTION-DIFFUSION SIMULATION OF ENZYME 
COMPARTMENTALIZATION REVEALS IMPROVED CATALYTIC 
EFFICIENCY FOR A SYNTHETIC METABOLIC PATHWAY
1
 
 
Introduction 
Enzyme-to-enzyme channeling (a.k.a. metabolic channeling) and 
compartmentalization of biochemical reaction modules have long been suggested as 
key components of cellular metabolism [67]. Metabolic channeling is a process 
whereby enzymes and their active sites are arranged in a manner that enables cells to 
effectively synthesize specific products without metabolic interference, diffusion 
limitations, or inhibition from intermediate steps [7,21,68]. The first direct evidence of 
this behavior came in the 1940‘s when David Green isolated all of the Krebs 
tricarboxylic acid cycle (TCA) enzymes as an aggregated system, which he termed a 
‗multienzyme complex‘ [69]. It is now apparent that metabolic channels are 
ubiquitous in nature and have evolved into several different physical forms including, 
for instance, tunneling between enzyme active sites that is clearly visible in the X-ray 
crystal structure [10], direct coupling between sequential pathway enzymes via 
protein-protein interactions [21], and compartmentalizing specific enzymes into small 
volumes within the cell in the form of subcellular organelles [70,71]. Likewise, 
engineered channels comprised of simple, coupled enzyme systems can reportedly 
improve the overall kinetic properties of the enzymes [72,73,74,75] as well as the 
                                                 
1
 Adapted with permission from: Conrado RJ, Mansell TJ, Varner JD, DeLisa MP (2007) Stochastic 
reaction-diffusion simulation of enzyme compartmentalization reveals improved catalytic efficiency for 
a synthetic metabolic pathway. Metab Eng 4:355-63. 
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metabolic flux through a pathway while reducing concentrations of intermediate 
species [11].  
Computer simulations of coupled enzyme networks have been instrumental in 
revealing the kinetic ramifications of enzyme channeling and compartmentalization 
[76,77,78,79,80,81]. The earliest models that explored channeling were deterministic 
and reported conflicting results both with respect to the ability of channels to exert 
greater metabolic control and to maintain low levels of pathway intermediates 
[76,77,78,81]; however, more recent approaches to modeling and simulation of 
metabolic networks unequivocally support the argument for channeling and its effect 
on cellular metabolism [79,80]. Specifically, Degenring et al. used a discrete event, 
multi-level model to analyze the interrelation between structural and functional 
characteristics of the static channeling that occurs in the tryptophan synthase complex. 
Maher et al. used Metabolic Control Analysis (MCA) and carefully accounted for 
enzyme compartmentalization to show that channeling in the urea cycle was required 
for the model output to reflect what was found in experiments. These two recent 
models highlight the importance of stochastic and spatial models, respectively, for 
metabolic pathway analysis and provide powerful mathematical tools to facilitate the 
analysis of channeling in biochemical pathways like the urea cycle or in multi-enzyme 
complexes like tryptophan synthase. 
Despite the greater accuracy that these and other modeling efforts have 
provided, there is little reliable simulation analysis on the kinetic benefits offered by 
coupled enzyme systems. Earlier modeling attempts have fallen short of answering the 
evolutionary benefit of channeling for several reasons: (1) coupled enzyme systems 
rely on the spatial organization of sequential enzyme steps; the reaction-diffusion 
relationship is crucial to channeling kinetics; and (2) the concentration of intracellular 
species is often low, especially with biological enzymes or channeled intermediates, 
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which deterministic models cannot capture; and while late modeling efforts have taken 
a more apt approach, they have not studied the enzyme kinetics thoroughly. For these 
reasons, a spatial and stochastic modeling approach could provide a more realistic 
portrayal of the system dynamics and capture the competing events within a cell. 
Accordingly, we have explored the effect of channeling within the context of 
biologically relevant pathways and parameters since complex interactions in metabolic 
networks can influence output in a non-trivial way and a realistic biological context is 
necessary to understand the effect of enzyme compartmentalization on specific 
pathways. 
Here, we present a spatial stochastic model of E. coli central carbon 
metabolism, including a description of energy metabolism within the cell, that relies 
on the combined recent advances in simulation methods, detailed kinetic biological 
models, and relevant biological pathways. Using this model, we simulate the addition 
of a pathway for the production of 1,2-PD to explore the kinetic consequences of 
enzyme compartmentalization on a synthetic pathway in the context of E. coli central 
carbon metabolism. Since bacterial production of 1,2-PD is hindered by the 
accumulation of the bactericidal intermediate methylglyoxal [82,83,84] and by the 
formation of undesired side products from competing pathways, it represents a unique 
opportunity for artificial enzyme compartmentalization as a means to increase 
production titers via the reduction of toxicity and side product formation. Furthermore, 
the techniques presented here provide a generic framework for simultaneously 
analyzing spatial and stochastic events in metabolism and, thus, should be useful in 
evaluating the contribution of enzyme compartmentalization within any recombinant 
pathway of interest. 
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Materials and methods 
Model structure. The stochastic model of central carbon and energy metabolism of E. 
coli was described by the Markov reaction diffusion master equation. The intracellular 
volume of E. coli was spatially divided into homogeneous three-dimensional 
subvolumes. The spatially discretized model was solved using the Next Subvolume 
Method (NSM) [85]. NSM provides an efficient implementation of the Gillespie 
Direct Method [86] coupled to a description of Stokes-Einstein diffusion between 
subvolumes. NSM allowed the central carbon metabolism of E. coli to be recast as a 
spatially heterogeneous reaction system where potential reaction events were defined 
with respect to a given subvolume and diffusion events occurred freely between 
connected subvolumes. 
 Two computational controls were conducted to validate our implementation of 
the NSM. First, simulations of the spatially homogenous stochastic reaction system 
DCBA kkk 321      (1) 
were compared to the analytical solution of the deterministic system. As shown in 
Figure 2.1A, the NSM solution is consistent with the true solution indicating the NSM 
was correctly implemented. A second computational control was conducted to gauge 
the impact of the kinetics upon the solution predicted by the NSM. The Markov 
reaction-diffusion master equation, typical of stochastic simulations, is most often 
associated with mass action propensity functions. Mass action kinetics require two 
parameters to describe the association/disassociation of the enzyme substrate complex 
and a third to describe the catalytic rate of the enzyme. Enzymes, however, are more 
commonly characterized in terms of their Michaelis-Menten parameters: a reaction 
velocity, kcat, and a saturation constant, Km. We have employed Michaelis-Menten rate 
forms, which are based upon a pseudo steady-state assumption, in our subsequent 
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Figure 2.1. Comparison between (A) species concentration (A -> B -> C -> D) using 
stochastic simulation (points) and analytical solution (lines) where k1=1s
-1
, k-1=2s
-1
, 
k2=2s
-1
; and (B) product formation using mass action (grey) and Michaelis-Menten 
kinetics (black) where k1=20s
-1
, k-1=1000s
-1
, k2=1000s
-1
, KM=100, kcat=1000s
-1
. Bound 
enzyme-substrate complexes in mass action kinetics are indicated by points. 
Compared simulations of the enzymatic conversion of substrate (S) to product (P) 
using mass action kinetics (Equation 2) and Michaelis-Menten kinetics (Equation 3): 
E S k1,k 1 ES k2 P E,     r1 = k1[E][S], r-1 = k-1[ES], r2 = k2[ES]     (2) 
E S koverall P E,     roverall = kcat[E][S]/(Km+[S])     (3) 
development. To test the impact of the pseudo steady-state assumption upon the NSM 
simulations, where enzyme was denoted by ‗E‘, enzyme-substrate complex ‗ES‘, 
kcat=k2, and Km=(k2+k-1)/k1 (Figure 2.1B). The close similarity between Michaelis-
Menten and mass action simulations justified the use of Michaelis-Menten kinetics 
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and demonstrated that the pseudo steady-state assumption was accurate over a 
stochastic regime. 
Kinetic rate expressions, with their parameters (Table A.1 and A.2), followed 
the form of traditional Michaelis-Menten equations for a variety of reaction types: 
forward and reversible, two-substrate, and various activation and deactivation 
schemes. In all reactions, a freely diffusive enzyme was additionally considered as an 
input to the rate expressions. 
E. coli reaction network model. The E. coli reaction network, fluxes, rate 
expressions, and kinetic parameters used in this study (Figure 2.2) were based upon 
the earlier work of Reuss and coworkers [87]. The Reuss network described glucose 
uptake via the phosphotranferase system, glycolysis, and the pentose phosphate 
pathway. We modified the Reuss network to include the TCA cycle, oxidative 
phosphorylation, and other cellular energetic reactions [88]. Because we are exploring 
the network response on time scales shorter than gene expression, we have assumed 
the enzyme number density to be constant for all of the cytoplasmic reactions [89]. 
The engineered R-1,2-PD metabolic pathway was modeled as three sequential steps 
that consume dihydroxyacetone phosphate (DHAP) and reducing power to form R-
1,2-PD [82]. In this study, E. coli methylglyoxal synthase (MGS; EC 4.2.99.11) 
converts DHAP to methylglyoxal (MG), which is then converted to R-lactaldehyde by 
a glycerol dehydrogenase (DhaD; EC 1.1.1.6) from Klebsiella pneumoniae. The 
intermediate, R-lactaldehyde is then converted to R-1,2-PD via an alcohol 
dehydrogenase (AdhI; EC 1.1.1.1) from Saccharomyces cerevisiae. As indicated in 
Figure 2.2, MGS releases inorganic phosphate, while DhaD and AdhI consume 
NADH. 
Enzyme compartmentalization. Enzyme compartmentalization confines an enzyme 
within a small volume or localizes an enzyme within the cell. In this study, 
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Figure 2.2. Metabolic model of glycolysis, pentose phosphate pathway and TCA 
cycle.
compartmentalized enzymes were prevented from freely diffusing, whereas diffusion 
of substrates was not constrained. All compartmentalized enzymes were confined to 
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the lower left hand subvolume, while all metabolites were allowed to freely diffuse 
(Figure 2.3). Non-compartmentalized enzymes were active and free to diffuse into any 
of the subvolumes. Under the NSM, the model of a single bacterium consisted of 
several well-mixed subvolumes in which species and enzyme populations were 
tracked. Analysis of enzyme compartmentalization proceeded by increasing the total 
number of subvolumes and concomitantly decreasing the size of the active enzyme 
compartment, as the total cell volume remained constant across simulations. Thus, as 
the subvolume dimensions were decreased, the local concentration of the confined 
enzymes increased, while their total cellular concentration remained constant. 
Evaluation of Michaelis-Menten kinetic parameters. The Michaelis-Menten 
parameters kcat and Km for AdhI were extracted from simulation data: first, the total 
extracellular rate of 1,2-PD production (V) was estimated from simulation data by 
dividing the difference in product concentration at two time points by the respective 
time difference (Figure 2.4A). An example Michaelis-Menten plot (V with respect to 
substrate concentration) generated by the simulation is shown (Figure 2.4B). Next, the 
value of V and the total cellular substrate concentration were used to create Eadie-
Hofstee plots (Figure 2.4C), from which Vmax and Km were determined. Finally, kcat 
was estimated by dividing Vmax by the total cellular enzyme concentration. The AdhI 
enzyme kinetics simulations were carried out assuming saturating amounts of NADH, 
thereby decoupling R-lactaldehyde conversion from reducing power limitations. 
Results and Discussion 
Comparison with experimental data. Stochastic simulations of the response of E. 
coli to a glucose pulse were compared to time-resolved intracellular metabolite 
measurements [87] obtained from fed-batch cultures of E. coli (Figure 2.5). The 
stochastic simulation tested for both one and two compartments captured the dynamic 
characteristics of the glucose pulse and described the observed trends for most 
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Figure 2.3. A sample discretization in a 2x2x1 subvolume as an example of enzyme 
compartmentalization. Here species (filled circle) can diffuse into any subvolume but, 
in this example, reactions are restricted to occur in the lower left subvolume. 
 
Figure 2.4. Calculation of Michaelis-Menten parameters from simulation data. Slope 
of product concentration with respect to time (A) is calculated to form a Michaelis-
Menten plot (B) and fitted on an Eadie-Hofstee plot (C) to extract Km and kcat.
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Figure 2.5. Comparison between experimental data
 
from Chassagnole et al. [87] 
(points) and stochastic simulation (lines) after a glucose pulse at time zero. (A) Solid 
line: simulation; filled circle: experimental data. (B1) Solid line: ATP; bold dotted 
line: AMP; dotted line: ADP; filled circle: ATP; filled triangle: AMP; filled square: 
ADP. (B2) Solid line: NADP; dotted line: NADPH; filled circle: NADP; filled 
triangle: NADPH. (B3) Solid line: NAD; dotted line: NADH; filled circle: NAD; filled 
triangle: NADH. 
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metabolites over a range of extracellular conditions (Figure 2.5A) using the single 
parameter set. Differences between model predictions and experimental observations 
were seen for FBP and PEP, with PEP showing significant deviation. However, unlike 
earlier models which used data driven descriptions of energy and reducing power, the 
energy and reducing state of the network was computed as part of our model. The 
profiles for most of the energetic co-metabolites, especially NAD derivatives (Figure 
2.5B), were correctly predicted by the model. Notable deviations from experimental 
data were observed primarily for ATP metabolism, which highlights the complexity of 
dynamically modeling central metabolism. The stochastic simulation results validate 
our description of E. coli central carbon metabolism and therefore lend the model to 
further engineering efforts, namely enzyme compartmentalization for an engineered 
metabolic pathway. 
Modeling and simulation of enzyme compartmentalization. To probe the impact of 
compartmentalization on 1,2-PD production, the recombinant 1,2-PD pathway 
enzymes were introduced into the full model of E. coli central carbon metabolism. 
Initial kinetic studies using the full model augmented with the compartmentalized 1,2-
PD pathway, for one and two subvolumes, revealed a sharp reduction in the Michaelis-
Menten saturation constant, Km, for the channeled substrate (Figure 2.6). That is, as 
the number of subvolumes increased, the saturation constant decreased. Here, a single 
subvolume system has well mixed enzymes, while in a two subvolume system, the 
recombinant enzyme reactions can occur in only one of the two subvolumes and 
substrates must diffuse into the compartmentalized subvolume before those enzymes 
may act on them. Although this study considers only the impact on kinetic properties 
for the third pathway enzyme, yeast AdhI, we expect this to be a general effect that is 
present at each step where the substrate is channeled. We next attempted to simulate 
the effect of further compartmentalization (i.e., subvolumes > 2) and the effects of 
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Figure 2.6. (A) Plot of Km for yeast AdhI comparison full (white) and simplified 
(grey) kinetic models for a substrate diffusivity of 16 mm
2
/s. Normalized (B) Km and 
(C) kcat / Km for compartmentalized enzymes versus freely diffusive enzymes plotted 
against the number of subvolumes. (open circle) D = 16 mm
2
/s; (open squard) D = 160 
mm
2
/s; (open triangle) D = 1600 mm
2
/s. (D) Concentration gradient of R-lactaldehyde 
under enzyme compartmentalization with 16 subvolumes at each diffusivity tested. All 
data points represent the average of three simulation runs with error bars representing 
the standard error. Geometries for the various numbers of subvolumes are as follows: 
1-1x1x1, 2-2x1x1, 4-2x2x1, 8-2x2x2, 16-4x2x2. 
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different reaction-diffusion regimes; however, simulation times became prohibitively 
expensive. To circumvent the issue of computational burden, we reduced the model to 
only the recombinantly expressed enzymes of the 1,2-PD pathway. The reduced model 
allowed us to explore the impact of compartmentalization on the utilization of carbon 
in detail. Since the reduced model neglects the dependence upon NADH, we assumed 
saturating reducing power in order to decouple the Michaelis-Menten kinetics and 
analyze the impact of compartmentalization on the channeled carbon substrate. 
Simulation times for the reduced model decreased by 100-fold; yet despite the drastic 
simplification of the model, the predictions were within 15% of the predictions made 
using the full E. coli reaction network (Figure 2.6A, compare white vs. grey bars). 
That is, both the full reaction network and the simplified recombinant pathway yielded 
similar results regarding the ability of enzyme compartmentalization to reduce the 
Michaelis-Menten saturation constant. Based on this observation, we were highly 
confident that the simplified model was a reliable surrogate for the full E. coli reaction 
network. 
Enzyme compartmentalization increases catalytic efficiency. Using the simplified 
model, we observed that compartmentalization of the 1,2-PD pathway led to a 
decrease in the overall Km when compared to the evenly distributed enzyme case 
(Figure 2.6B). The decrease in Km was magnified by increasing the number of 
subvolumes i.e., increasing the degree of enzyme compartmentalization. The decrease 
in Km was accompanied by a small (≤10%) decrease in kcat and, as a result, an overall 
increase in catalytic efficiency (kcat / Km) (Figure 2.6C) was observed. The increase in 
catalytic efficiency was dependent upon substrate diffusivity. Substrate diffusivity, D, 
for a wide range of biologically relevant species where D for ions > small molecules > 
enzymes was simulated; the effect of compartmentalization increased with decreasing 
substrate diffusivity (Figure 2.6). The impact of compartmentalization was greatest at 
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the lowest substrate diffusivity (D = 16 mm
2
/s) [5,90], but was still present even at 
small-molecule-like diffusion rates (D = 160 mm
2
/s) [91,92]. Values for Km were 
shown to decrease up to 6-fold relative to the case of non-compartmentalized enzymes 
for slow diffusing substrates, and up to 20% for normal diffusing small molecules. 
There was little to no effect on the Km for faster diffusing ion-like species (D = 1600 
mm
2
/s). It was expected that enzyme compartmentalization would impact the apparent 
Km but not the apparent kcat, since the relationship between substrate concentration and 
reaction velocity is intrinsic to Km itself. 
To explain the inverse relationship observed between the apparent Km and 
enzyme compartmentalization we formulated the working hypothesis that the decrease 
in Km was due to an increase in the local concentration of substrate in the 
compartmentalized subvolume. In other words, increased enzyme concentration in the 
active compartment leads to a local buildup of pathway intermediates. In the regime 
below Km, where many engineered metabolic reactions lie, reaction velocity is directly 
proportional to the substrate concentration. Therefore, a local buildup of intermediates 
would be expected to increase the overall enzymatic reaction velocity. To test our 
working hypothesis, we plotted the concentration of the pathway intermediate R-
lactaldehyde (the substrate of yeast AdhI) in each subvolume when the total cellular 
concentration of R-lactaldehyde was equal to one quarter of its Km (Figure 2.6D). A 
significant concentration gradient of R-lactaldehyde was observed in the slowest 
diffusing case (D = 16 mm
2
/s), with the localized intermediate concentrated in the 
compartmentalized subvolume by as much as 4-fold over the average cellular levels. 
However, this gradient was much smaller for faster diffusing cases (D ≥ 160 mm2/s), 
demonstrating that this effect depended greatly on substrate diffusivity and verifying 
our initial hypothesis. Increasing the diffusivity of the substrates effectively rendered 
the cell well-mixed for the pathway intermediates and tended to negate the apparent 
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effect of local concentration, thus reducing the impact on Km. Thus, the kinetic 
improvements demonstrated by enzyme concentration are likely to be much more 
evident for cases of low substrate diffusivity [75,93]. 
To our knowledge, the above results represent the first attempt to model 
substrate channeling for a synthetic metabolic pathway, comprised of enzymes that are 
expressed recombinantly in E. coli. Our finding that enzyme compartmentalization can 
yield improved catalytic efficiency agrees well with experiments where engineered 
fusion proteins were created to mimic enzyme compartmentalization [73]. Though not 
directly studied here, the kinetic benefits that we observed could have important 
consequences for product formation. Channeling has shown to have a dramatic impact 
on rate without a significant impact on the measured kinetic properties of enzymes 
involved [36,72,75]. Further, naturally occurring bacterial compartments exist for the 
degradation of small molecules like 1,2-PD [70] and therefore point to the important 
benefits provided by channeling even when the impact on kinetic parameters may be 
slight. This suggests that the kinetic shift seen during our simulations is significant 
from an evolutionary standpoint and is even more important for larger molecules. 
Examples of channeling for the production of slow diffusing species is seen in 
aromatic amino acid synthesis [10,18,94], plant phenylpropanoid metabolism [29] and 
the bacterial PKS system [95]. In addition to the results presented in this work, we 
hypothesize that channeling will contribute further benefits to the bacterial production 
titers of 1,2-PD. These include: (1) sequestration from competing reaction pathways 
which are present in the cell but not considered in our model; (2) reduction of kinetic 
constraints on the cell by lowered intermediate concentrations; and (3) rapid 
conversion of MG to R-lactaldehyde, which is significant because MG is bactericidal 
at sub mM concentrations [3]. For these reasons, the production of 1,2-PD is an 
appropriate target for the creation of synthetic metabolic channels. 
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In considering the marked improvements made possible by enzyme 
compartmentalization, there are several factors one must take into account before 
embarking on the engineering of a channeled recombinant pathway. Of primary 
consideration, channeling has evolved in cases where the native enzymes have poor 
efficiency or low substrate specificity, other constraints being absent. Those enzymes 
that have a low Km or high catalytic activity never allow substrate to build up and are 
already operating at near maximal efficiency. Traditional recombinant metabolic 
pathways, however, suffer from poor translation efficiency, are present in highly 
variable copy numbers, and have low turnover for new substrates, which this study 
directly considers. Another key constraint is the limited availability of energy and 
reducing power in the cell. Although not considered here, further enzyme 
compartmentalization could be envisioned to produce both ATP and NADH. Enzyme 
compartmentalization presents an excellent opportunity for improving the kinetic 
properties for the channeled carbon substrate. Ongoing research is directed towards a 
more comprehensive approach for understanding the full impact of substrate 
channeling, including the changes in system flux, intermediate concentrations, and rate 
of product formation. 
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CHAPTER 3 
 
ENGINEERING ENZYME COLOCALIZATION FOR PRODUCTION OF  
1,2-PROPANEDIOL AND 1,2,4-BUTANETRIOL IN E. COLI 
 
Introduction 
Enzyme-to-enzyme channeling (a.k.a. metabolic channeling) and 
compartmentalization of biochemical reaction modules have long been suggested as 
key components of cellular metabolism [67]. Metabolic channeling is a process 
whereby enzymes and their active sites are arranged in a manner that enables cells to 
effectively synthesize specific products without metabolic interference, diffusion 
limitations, or flux imbalances [7,21,68]. The first direct evidence of this behavior 
came in the 1940‘s when David Green isolated all of the Krebs tricarboxylic acid 
cycle (TCA) enzymes as an aggregated system, which he termed a ‗multienzyme 
complex‘ [69]. It is now apparent that metabolic channels are ubiquitous in nature and 
have evolved into several different physical forms including, for instance, tunneling 
between enzyme active sites that is clearly visible in the X-ray crystal structure [10], 
direct coupling between sequential pathway enzymes via protein-protein interactions 
[21], and compartmentalizing specific enzymes into small volumes within the cell in 
the form of subcellular organelles [70,71]. Likewise, engineered channels comprised 
of simple, coupled enzyme systems can reportedly improve the overall kinetic 
properties of the enzymes [72,73,74,75] as well as the metabolic flux through a 
pathway while reducing concentrations of intermediate species [11].  
The intentional engineering of metabolic pathways is a rapidly maturing field 
and much attention has already been given to cellular productivity and diverted flux. 
Indeed, a number of strategies have been reported for optimizing cellular metabolism 
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including, for example, stabilizing mRNA transcript levels, balancing protein 
expression levels, evolving enzyme activity, and redirecting cellular metabolism [34]. 
These successes notwithstanding, very little attention has been given to the spatial 
organization of the recombinant metabolic pathway enzymes in vivo. Yet, based on 
numerous examples from nature, it is clear that enzyme organization is a key design 
variable to be considered when engineering metabolism.  
Engineering efforts have made great strides at mimicking these natural 
systems, moving from immobilized enzymes [35] to fusion proteins [40] to post-
translational assembly of metabolic enzymes along a scaffold chimera [39]. However, 
there have been few intentional and successful attempts to channel metabolic 
substrates within the cytoplasm of E. coli [96]. The high number of demonstrated 
improvements in vitro motivates the need for a generic toolkit for colocalizing a 
sequential series of enzymes for cellular production. Early engineering attempts have 
fallen short for several reasons: (1) fusion chimeras often fail to fold properly within 
the cell and are rapidly degraded; and (2) colocalized enzymes that do fold, frequently 
suffer from a reduction in activity that masks any potential benefits of channeling. 
While genetic techniques have improved dramatically since immobilized enzyme 
technology, these have largely not been applied to the creation of active 
compartmentalized enzyme pathways. Accordingly, we have explored the parameters 
involving colocalized enzymes and mimicked techniques thus far only successful in 
vitro, to create increasingly elegant methods to colocalize enzymes in the cytoplasm of 
E. coli. 
Here, we present a study of enzyme colocalization for the production of both 
1,2-propanediol and 1,2,4-butanetriol from three and four enzymatic steps that branch 
from E. coli central carbon metabolism. Since bacterial production of 1,2-PD is 
hindered by the accumulation of the bactericidal intermediate methylglyoxal 
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[82,83,84] and by the formation of undesired side products from competing pathways, 
it represents a unique opportunity for artificial enzyme compartmentalization as a 
means to increase production titers via the reduction of toxicity and side product 
formation. Furthermore, 1,2,4-BT production suffers from a myriad of competing 
reactions, both known and unknown, that dramatically limit its production in vivo. The 
techniques presented here provide a generic framework for creating colocalized 
enzymes and should be useful in evaluating the contribution of enzyme 
compartmentalization within any recombinant pathway of interest. 
Materials and methods 
1,2-PD biosynthesis pathway. Plasmids were constructed using molecular biology 
techniques according to standard practices [97]. The three sequential genes for 
encoding 1,2-PD biosynthesis, (1) mgsA, (2) dkgA, dkgB, fucO, or ydjG and (3) gldA 
were PCR amplified from E. coli MG1655 genomic DNA. These genes were then 
cloned into pBAD18 [98] in the order shown, using unique restriction sites within the 
multiple cloning site, resulting in a polycistron for 1,2-PD synthesis. The first gene 
was placed between NheI and XbaI, the second gene between XbaI and SphI, and the 
last gene between SphI and HindIII. The same strong ribosomal binding site was 
placed directly upstream of each gene in the polycistron and an NdeI site at each start 
codon. At times, the second biosynthetic gene was appended by an 3‘ HA epitope tag 
and gldA was appeneded by a 3‘ FLAG epitope tag.  
1,2,4-butanetriol biosynthetic pathway. Plasmids were constructed using molecular 
biology techniques according to standard practices [97]. The four sequential genes for 
encoding 1,2,4-BT biosynthesis, (1) xdh (C. crescentus), (2) yagF or yjhG (E. coli), 
(3) mdlC (P. putida) and (3) adhP (E. coli) were PCR amplified and cloned into 
pBAD18 [98] in the order shown, using unique restriction sites within the multiple 
cloning site, resulting in a polycistron for 1,2,4-BT synthesis. xdh was PCR amplified 
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from pWN9.046A and placed between EcoRI and BglII restriction sites. yjhG was 
PCR amplified from pWN8.022 and yagF was PCR amplified from E. coli MG1655 
genomic DNA and placed between BglII and XbaI restriction sites. mdlC was PCR 
amplified from pWN5.238A and placed between XbaI and HindIII restriction sites. 
adhP was PCR amplified from pML6.166 and placed between HindIII and NcoI 
restriction sites. The same strong ribosomal binding site was placed directly upstream 
of each gene in the polycistron and an NdeI site at each start codon.  
Fusion proteins. The fusion proteins were generated using codon optimized peptide 
linkers {Chang, 2005 #220}, with the linkers flanked by SpeI and NotI restriction 
sites. The restriction sites flanking the biosynthesis genes were maintained. As a 
control for fusion proteins for 1,2-PD, MalE was cloned into the C-terminal position 
of the fusion with MgsA, allowing the gene in the second position to be freely 
expressed. At times, fusions were appended with a 3‘ HA epitope tag.  
Post-translational interacting domains (PIDs). PIDs were generated using GCN4-
GCN4 [99], cJun-cFos, and SH3-SH3lig [66] interacting pairs. GCN4, cJun were PCR 
amplified [99] and fused C-terminally to mgsA using an L16 polylinker [64]. GCN4 
and cFos fragments were PCR amplified [99] and fused N-terminally to either dkgA or 
fucO using an L16 peptide linker [64]. The strong binding SH3 ligand (SH3ligS) were 
fused C-terminally to mgsA using an L16 linker [64]. The SH3 domain was PCR 
amplified from pET19(a): B.3.1 [66] and fused N-terminally to either DkgA or FucO 
using an L16 linker [64]. As controls to reduce the binding affinity of these ligands, 
GCN4 (7P14P) [99], cJun (L3V) and cFos (L2V) [99], and the weak binding SH3 
ligand (SH3ligW) [66] were employed in the same context as the strong binding 
counterpart. 
Protein Scaffolds. The SH3-PDZ-GBD protein scaffold was PCR amplified from 
pET19(a): B.3.1 [66] and fused to the C-terminus to MalE (E. coli) with an L16 
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peptide linker [64] and additionally contained a C-terminal HA epitope tag. This 
construct was cloned into the MCS of both pBAD18Cm and pBAD33Cm [98]. 
Scaffold ligands [66] were fused N-terminally to the 1,2-PD biosynthetic enzymes 
with an L16 peptide linker [64]: SH3 ligand fused to mgsA, PDZ ligand fused to 
dkgA, and GBD ligand fused to gldA. 
Bacterial strains, media, and growth conditions. E. coli MC4100 [F
−
 
araD139Δ(argF-lac)U169 rspL150 relA1 flbB5301 fruA25 deoC1 ptsF25] or its 
derivatives were used for 1,2-PD production unless otherwise noted. 1,2-PD 
fermentations were followed as described [82] with the following exceptions. L-
arabinose was added to 0.2% (w/v) at the time of inoculation to induce gene 
expression. All fermentations were run at 37°C, either at 200 or 250 rpm, with tubes 
held vertically or at a 45 degree angle. The 10-mL fermentation mixtures were 
inoculated to an optical density of 0.05 (typically 1:50 to 1:100 dilution) with the 
overnight culture. The optical density (OD) was measured at 600 nm with a Thermo 
Spectronic BioMate 3 model spectrophotometer.  
E. coli BW25113 [∆(araD-araB)567, ∆lacZ4787(::rrnB-3), lambda-, rph-1, 
∆(rhaD-rhaB)568, hsdR514] or its derivatives were used for 1,2,4-BT production 
unless otherwise noted. BW25113 derivatives were constructed by P1 transduction 
from the Keio Collection [100]. 1,2,4-BT fermentations were followed as described 
[101,102,103] with the following exceptions. Overnight cultures were grown from a 
single colony into 5 mL of LB media. All fermentations were run in 20 mL of rich 
media (20 g/L tryptone, 10 g/L yeast extract, 5 g/L NaCl, 3.75 g/L K2HPO4) in 250-
mL baffled flasks at 33°C, 250 rpm for 24 hours. D-xylose was added to 2% (w/v) at 4 
hours. L-arabinose was added to 0.2% (w/v) to induce gene expression at 4 hours. The 
20-mL fermentation mixtures were inoculated to an optical density of 0.05 (typically 
1:50 to 1:100 dilution) from the overnight culture. Antibiotics were provided at the 
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following concentrations: ampicillin, 100 μg/mL; chloramphenicol, 20 μg/mL. 
HPLC analysis. Products in the fermentation media were quantified as described [82] 
with the following exceptions. Compounds were measured with a Waters Breeze 
system. The mobile phase was a 0.03 N sulfuric acid solution, with a flow rate of 0.45 
ml per min, and the column temperature was 50°C. All samples were filtered through 
0.22-μm-pore-size membranes prior to analysis. 
Western blot analysis. MC4100 cultures were grown overnight in LB media, 
inoculated as above, lysed via sonication after either 9 or 24 hours, and normalized on 
the amount of total soluble cell protein. Insoluble lysates were isolated by 
centrifugation at 16,000 g for 10 minutes. Pellets were washed twice with 1 mL of 
with Tris-Cl (50 mM) and EDTA (1 mM) pH 8.0. The pellet is then resuspended in 1x 
PBS and 2% SDS and then boiled for 10 minutes. The insoluble fraction is collected 
as the supernatant following a 10 minute centrifugation at 16,000 g. Western
 
blotting 
of these soluble and insoluble lysates was performed with anti-HA primary antibody 
(1:1000, v/v; Sigma) and anti-rabbit secondary antibody (1:2500, v/v; Promega) on 
SDS-PAGE gels, typically 10 or 12%. 
Results 
Enzyme Compartmentalization Towards Production of 1,2-Propanediol. In order 
to construct a synthetic metabolic pathway from DHAP to R-1,2-PD, we first needed 
to identify three sequential pathway enzymes (Figure 3.1). Since natural reaction 
pathways consume R and S-lactaldehyde for reduction to lactate, a route through the 
acetol intermediate would suffer from less diverted flux. Along this path, the first and 
last enzymatic steps were well-defined, specifically the synthesis of methylglyoxal by 
methylgloxal synthase (MgsA, E. coli) and reduction of acetol by glycerol 
dehydrogenase (GldA, E. coli) [82]. However, the reduction of the intermediate, MG 
to acetol, can be performed by a number of NADH or NADPH dependent enzymes 
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Figure 3.1. Metabolic pathway of 1,2-PD production from dihydroxyacetone 
phosphate in E. coli.  
[104], most of which have not been tested in vivo. To test for activity on 
methylglyoxal in vivo, a high copy plasmid expressing MgsA, one of the following 
NADH (FucO, YdjG, E. coli) or NADPH dependent enzymes (DkgA, DkgB, E. coli), 
and GldA [104] was constructed. As shown in Figure 3.2, all genetic constructs 
produced significant levels of 1,2-PD, which allowed enzyme selected based upon our 
design criteria. In moving forward, DkgA was selected for primary focus because its 
kinetic parameters are well defined and it is active as a monomer, which would aid in 
the design and analysis of metabolic channels. 
Fusion Proteins Towards 1,2-PD. Since fusion proteins are a well-studied example 
[96], and are a simple test for analyzing the impact of enzyme compartmentalization, 
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Figure 3.2. The effect of methyglyoxal reductase activity on 1,2-PD production. The 
above enzymes were overexpressed along with MgsA and GldA. Columns represent 
the average of three experiments with error bars showing one standard error. 
 
Figure 3.3. Engineering enzyme compartmentalization. (A) Fusion proteins connected 
by a peptide linker, (B) Chimeric proteins fused to leucine zippers connected by post-
translational assembly of PIDs, (C) Post-translational assembly of enzyme complexes 
where the SH3-PDZ-GBD fusion represents the three specific docking sites for each 
enzyme-ligand fusion. 
engineering our pathway enzymes by genetic fusion was a natural first step, to 
covalently attach two enzymes by encoding both active sites on the same polypeptide 
(Figure 3.3A). In this way, the active sites could be brought into close proximity and 
therefore allow for the proposed synergistic activity found in natural systems [68]. In 
order to systematically test this approach, the two design elements considered were (1) 
the linker length and composition and (2) the order of the protein fusions within the 
context of the entire pathway. Despite a large body of knowledge regarding natural 
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linkers within multidomain proteins [105], there is little consensus on the length and 
composition of synthetic linkers when connecting two proteins that are normally not 
fused [96].  
In order to find a suitable candidate, we systematically applied a set of 6 well-
studied linker peptides between fusion proteins in E. coli, which varied in composition 
and length, from 5 to 37 amino acids [64]. This approach allowed us to test role of the 
linker in terms of its effect on protein stability, as well as the effect of linker length on 
the degree of synergistic coupling, i.e., if the kinetic benefit disappeared with longer 
linkers due to the increased diffusional distance. This resulted in several in-frame 
genetic fusions between the first two enzymatic steps of the pathway, mgsA and dkgA, 
with the third enzyme freely expressed in a bicistronic message. As shown in Figure 
3.4, a modest 30% increase in 1,2-PD production was found when the fusions were 
compared to the fusion of MgsA to a soluble but inactive protein partner, MalE. 
MgsA, a hexamer in its active state, is very sensitive to fusions at either its N or C-
termini. In order to assess any synergy that occurs between MgsA or DkgA in vivo, 
this control was most appropriate. The modest gain in activity through the pathway is 
consistent with computational studies on compartmentalization in E. coli [12].  
These results prompted us to determine whether or not a greater benefit could 
be seen when fusing only the second two pathway enzymes, thus channeling acetol 
towards 1,2-PD. Applying the same set of linkers, genetic fusions were created 
between dkgA and gldA, and with free mgsA encoded bicistronically. Interestingly, this 
set of fusion constructs (Figure 3.5) had little impact on yield with the best linkers 
tested, suggesting that no kinetic benefit was observable and/or that these fusions were 
not well tolerated. 
As a final goal of compartmentalizing a set of sequential pathway enzymes, a 
three-gene fusion was constructed, to determine if a fold improvement could be 
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Figure 3.4. Effect of enzyme fusions between of MgsA and DkgA on 1,2-PD, 
production, while coexpressing GldA. The name of each sample indicates the linker 
employed with the number denoting the linker length in amino acids. The control 
sample is an MgsA-MalE enzyme fusion, coexpressing DkgA and GldA. Columns 
represent the average of three experiments with error bars showing one standard error. 
 
Figure 3.5. Effect of enzyme fusions between of DkgA and GldA on 1,2-PD 
production, while coexpressing MgsA. The name of each sample indicates the linker 
employed with the number denoting the linker length in amino acids. The control 
sample has MgsA, DkgA, and GldA coexpressed without fusion. Columns represent 
the average of three experiments with error bars showing one standard error. 
detected over the mgsA-dkgA fusions due to altered kinetics over the free enzymes 
(Figure 3.4). Selecting successful linkers in both cases, the L16 linker was used 
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between the first two pathway enzymes and the L37 linker between the last two 
enzymes, thus making an MgsA-L16-DkgA-L37-GldA fusion. After being 
constructed, these were compared to the corresponding free and fusion enzyme 
systems by their production of 1,2-PD (Figure 3.6). Combining the fusions between all 
pathway genes did not yield an improvement over the simple fusion of the first two 
enzymes. This was not altogether surprising since the fusion of the last two enzymes 
seemed to impair enzyme activity from the decrease in 1,2-PD production (Figure 
3.5). In probing for the explanation for these disparate levels of production, a Western 
Blot was performed to analyze the intracellular protein levels, which might be 
impacted from these novel fusions. In comparing the protein levels of these selected 
fusions however, the soluble protein levels are very similar, despite fusions involving 
MgsA having significant insoluble fractions (Figure 3.7). This result suggests that 
these fusion proteins have significantly impaired individual activities despite having 
decent folding characteristics. It is also important to note that the first and last 
enzymes of the pathway enzymes are multimeric, and the active structures are denoted 
MgsA6, DkgA, and GldA8. Combining these polypeptides by gene fusion, especially 
when combining more than two genes as above, can have important consequences in 
terms of aggregation and achieving active enzyme units (Figure 1.3 and [96]). While 
aggregation may be a general problem with compartmentalizing multimeric enzymes, 
it is important to pursue alternative strategies that might allow these to form in a 
manner that they maintain activity. 
Protein Interacting Domains (PIDs) Towards 1,2-PD. In moving beyond protein 
fusions as a result of the fusion loss in activity when colocalizing two or more, the 
enzyme active sites should be coupled in a way that would allow proper protein 
folding, and possibly subunit assembly, before compartmentalizing the pathway 
enzymes. Similar to the assembly of metabolic channels like the tryptophan synthase 
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Figure 3.6. Effect of enzyme fusion on 1,2-PD production. Free denotes all enzymes 
coexpressed without fusion. 1-2,3 denotes a fusion of MgsA and DkgA with GldA 
freely expressed. 1,2-3 denotes a fusion of DkgA and GldA with MgsA freely 
expressed. 1-2-3 denotes a tripartite fusion between MgsA, DkgA, and GldA. 
Columns represent represent a single experiment. 
 
Figure 3.7. Western Blot of soluble (S) and insoluble (I) protein levels on samples of 
Figure 3.6.  
 complex [10], a post-translational, non-covalent assembly of sequential 
pathway enzymes would likely allow for more stable enzyme formation of active 
multimers. To achieve this, known protein interacting domains were employed, that 
when fused N- or C-terminally to the pathway enzymes, would bind together and 
would thus bring the sequential active sites into close proximity (Figure 3.3B). This 
strategy offers more design flexibility than gene fusion above, because in addition to 
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design of the linker region, there are also considerations for the binding associations, 
homo- or heterodimerization, and their affinity in terms of the dissociation constant, 
KD. Here our design criteria were domains that: (1) are well expressed in E. coli, 
(2)possess high affinity interactions in the M to sub- M range, given that natural 
proteins can reach 1-10 M concentrations in E. coli [89], (3) are short in length, 
preferably <50 amino acids, (4) are characterized by highly specific interactions with 
little cross-reactivity. Based on these standards, we selected three sets of interacting 
domains for further analysis: GCN4 [106], cJun-cFos [107,108,109,110], and the SH3 
domain and associating ligand [66]. These domains were then fused to each of the first 
two pathway enzymes with the third enzyme freely expressed. The degree of 
synergistic effect was measured by comparison to a polycistronic free enzyme system, 
where either the first or second pathway enzyme was fused to a PID. In this way, the 
domain would similarly impact activity, but not enable interaction. Additionally, the 
PIDs offer further controls in that in each of these interacting domains, (1) PIDs can 
be tested individually for their impact on enzyme activity and (2) point mutations can 
be made to reduce binding affinity. These additional controls should help to elucidate 
the mechanism of the fold-improvement seen in protein fusions, namely whether the 
increase was due to enzyme compartmentalization or an increase in protein stability as 
seen by Western Blot. 
These constructs were analyzed as above for their extracellular 1,2-PD 
production levels following fermentation, shown in Figure 3.8, with each of the 
interacting domains and the inactivating control. Interestingly for the DkgA, the 
GCN4 leucine zippers were responsible for the largest increase in production, 
followed by either cJun/cFos or the SH3/SH3ligand pair. Looking towards the controls 
for each of these interacting domains, the inactivating mutations to GCN4 [111], had a 
slight decrease in 1,2-PD levels, and this trend is similar for each of the interacting 
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Figure 3.8. Effect of PIDs on both MgsA and DkgA on 1,2-PD production, while 
coexpressing GldA. The name of each sample indicates the PID pair employed where 
(+) denotes full interaction strength, and the (-) denotes mutated PIDs to reduce 
binding affinity. Control 1 has a PID on MgsA only, and control 2 has a PID on DkgA 
only. Columns represent the average of three experiments with error bars showing one 
standard error. 
domain pairs. While none of the PIDs show a significant increase in production of 1,2-
PD over the controls, each slightly outperforms its weakly interacting pair.  
Orientation of Fusions and PIDs Towards 1,2-PD. When compared to the 
metabolic enzymes alone, both fusions and PIDs suffered from loss of activity. As a 
method to ameliorate this impact, the opposite orientation fusion was constructed, as 
well as PIDs at either termini of the protein, using the same domains and peptide 
linkers. As shown in Table 3.1, the fusion orientation matter greatly, both for protein 
fusions and post-translational interactions and with pathways expressing DkgA and 
FucO, however, none of the orientations tested showed improvements over the free 
enzyme system. 
Protein Expression Level and Its Impact on Synergy Towards 1,2-PD. Since none 
of the systems tested to date showed marked improvements in levels of 1,2-PD, one 
explanation was that the over-expressed enzyme levels within the cell were too highly 
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Table 3.1. Effect of fusion and PID orientation on 1,2-PD production, while 
coexpressing GldA. Values given in grams per liter. Data represent a single 
experiment. 
FucO   
Free (+GldA) MgsA; FucO 1.59 
Fusion (+GldA) MgsA-L16-FucO 1.03 
 FucO-L16-MgsA 0.76 
PIDs (+GldA) MgsA-L16-cJun cJun-L16-MgsA 
FucO-L16-cFos 1.21 1.23 
cFos-L16-FucO 0.66 0.60 
DkgA   
Free (+GldA) MgsA; DkgA 1.22 
Fusion (+GldA) MgsA-L16-DkgA 0.87 
 DkgA-L16-MgsA 0.54 
PIDs (+GldA) MgsA-L16-cJun cJun-L16-MgsA 
DkgA-L16-cFos 0.59 1.00 
cFos-L16-DkgA 0.47 0.70 
for the benefits of enzyme colocalization to have any impact. To test this, relevant 
plasmids were transformed into WM2949 cells harboring pLacY(A177C) [112]. This 
combination allows for leaky transport of arabinose and therefore titratable induction 
of the PBad promoter, instead of the on/off phenotype observed in MC4100. In this 
way, a comparison between free and colocalized enzymes could be made at wide 
range of induction levels, and the corresponding range of enzyme levels (Figure 3.9). 
Interestingly however, the free enzyme case performed better at all levels of induction, 
when compared to fusion proteins and PIDs. Even at very low expression levels, 
neither fusion proteins nor PIDs showed an increase in 1,2-PD production, indicating 
that no synergy was observable.  
Coexpression of Free Enzymes Towards 1,2-PD. Within this work, enzyme 
colocalization has shown only very modest improvements, and only in very isolated 
cases. One explanation for this is the assembly conundrum that is present when 
multimeric enzymes are attached, by fusion of PID (Figure 1.3). The enzymes that 
participate in this matrix may have reduced activity if any. To circumvent this, the 
three metabolic enzymes were freely expressed from a separate plasmid and 
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Figure 3.9. Effect of arabinose induction level on 1,2-PD production. Empty: no 
overexpressed enzymes; Free: MgsA, DkgA, and GldA overexpressed; Fusion: MgsA-
L16-DkgA, and GldA overexpressed; and PID: cJun-L16-MgsA, DkgA-L16-cFos, and 
GldA overexpressed. Columns represent a single experiment. 
colocalized enzyme constructs were coexpressed. This effect can be modulated by 
high expression of colocalized enzymes (from pBAD18) and low expression of free 
enzymes (pZA31) or vice versa. As show in Figure 3.10 for DkgA and Figure 3.11 for 
FucO, coexpressing free enzymes from two plasmids at the same time showed very 
little increase, although coexpressing free enzymes did improve the colocalized 
enzyme cases to the level of free enzymes. This final results gives further support that 
no synergy between colocalized enzymes is observable towards 1,2-PD. 
Protein Scaffolds Towards 1,2-PD. Neither fusions proteins or interacting domains 
were very successful in increasing the yields of 1,2-PD for even two-enzyme channels, 
and this effect became more evident with colocalizing three enzymes. Insolubility of 
these complexes and loss of activity hinders the ability to benefit from even slight 
synergy between colocalized enzymes. Further, flux imbalances within the pathway 
have been overlooked and may be responsible for the lack of improvement. The move 
away from fusions and PIDs is motivated both by the membrane bound metabolons  
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Figure 3.10. Effect of free enzyme coexpression on 1,2-PD production. Empty: no 
overexpressed enzymes; Free: MgsA, DkgA, and GldA overexpressed; Fusion: MgsA-
L16-DkgA, and GldA overexpressed; and PID: cJun-L16-MgsA, DkgA-L16-cFos, and 
GldA overexpressed. Columns represent a single experiment. 
 
Figure 3.11. Effect of free enzyme coexpression on 1,2-PD production. Empty: no 
overexpressed enzymes; Free: MgsA, FucO, and GldA overexpressed; Fusion: MgsA-
L16-FucO, and GldA overexpressed; and PID: cJun-L16-MgsA, FucO-L16-cFos, and 
GldA overexpressed. Columns represent a single experiment. 
found in nature [21] and the chimeric cellulosomes tested in vitro [56]. Using the basic 
structure of these chimeric cellulosomes, a fusion protein consisting of several 
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Table 3.2. Effect of colocalizing enzymes to a protein scaffold on 1,2-PD production. 
Free: MgsA, DkgA, and GldA overexpressed; and Ligands: MgsA-L16-SH3ligand, 
DkgA-L16-PDZligand, and GldA-L16-GBDligand. Scaffold (MBP-L16-SH3-PDZ-
GBD) was overexpressed in either pBAD18Cm or pBAD33Cm, where empty has no 
scaffold. Values given in grams per liter. Data represent a single experiment. 
 pBAD18Cm pBAD33Cm 
 Scaffold Empty Scaffold Empty 
Free 1.04 1.10 0.92 0.82 
Ligands 0.22 0.17 0.19 0.23 
docking domains connected by peptide linkers was constructed (Figure 3.3C). The 
pathway enzymes can then colocalize on this scaffold by several short ligands, which 
specifically target each of these docking domains. As the number and order of these 
scaffold domains was varied, so to would the metabolic enzymes, creating a 
mechanism to balance flux. 
Since the docking and ligand domains from these engineered cellulosomes are rather 
large and were not tested in vivo, a protein scaffold recently developed to tightly 
control input/output signals was employed as a proof of concept [66]. Using the SH3-
PDZ-GBD scaffold construct from this work, the corresponding strong ligands were 
fused to each of the individual pathway enzymes. When this scaffold was tested for 
levels of 1,2-PD, compared to same vector lacking the scaffold, no significant increase 
in 1,2-PD resulted at either high (pBAD18) or low (pBAD33) expression of the 
scaffold (Table 3.2). Looking into this further, the expression of the scaffold was then 
analyzed by Western Blot, along with its codon-optimized counterpart, with and 
without fusion to MalE. Not surprisingly the scaffold expresses very poorly in E. coli 
(Figure 3.12), is not detectable without fusion to MalE, a known solubility enhancer 
[113]. Due to the significant amount of protein degradation and lack of scaffold 
solubility, this approach was abandoned.  
Enzyme Compartmentalization towards Production of 1,2,4-Butanetriol. In order 
to validate our approach towards colocalizing enzymes, it was important to test
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Figure 3.12. Western Blot of soluble (S) and insoluble (I) scaffold expression levels. 
From left to right: native and codon optimized constructs of SH3-PDZ-GBD scaffold, 
followed by native and codon optimized constructs of MalE-L16-SH3-PDZ-GBD 
scaffold. 
another metabolic pathway, whose enzymes had different kinetic parameters and 
multimeric states and whose substrates had different diffusivities. The production of 
1,2,4-BT stands as such an example and can be produced in E. coli from four 
enzymatic steps from xylose (Figure 3.13) [102]. Initial tests to produce 1,2,4-BT in E. 
coli failed to produce significant yields, despite overexpression of two version of the 
metabolic pathway, and knockout of xylA, which competes for the xylose substrate 
(Figure 3.14) [114]. In order to increase the levels of 1,2,4-BT so comparison to 
colocalized enzyme constructs were possible, several gene knockouts were tested 
(Figure 3.14). Both YagE and YjhH are hypothesized to compete for the second 
intermediate so it is [114] not surprising that we observed increases in yield as well 
when these enzymes were absent. In further testing, a xylA yjhH double mutant was
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h)a) D-xylosedehydrogenase, C. crescentus, Xdh
b) D-xylonatedehydratase, YjhGand YagF
c) benzoylformatedecarboxylase, P. putida, MdlC
d) alcohol dehydrogenase, AdhP
e) D-xyloseisomerase, XylA
f) 2-keto acid aldolase, YagE and YjhH
g) 2-keto acid dehydrogenase
h) 2-keto acid transaminase
i) aldehydedehydrogenase
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Figure 3.13. Metabolic pathway of 1,2,4-butanetriol production from xylose E. coli. 
Courtesy of John Frost (Department of Chemistry, Michigan State University). 
 
Figure 3.14. The effect of pathway and gene deletion on 1,2,4-butanetriol production. 
The above enzymes were overexpressed in the given E. coli knockout. Data represent 
a single experiment. 
 employed as it produced a high yield of 1,2,4-BT and by maintaining the competing 
enzyme, YagE, benefits of channeling could be readily observed. 
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Figure 3.15. Effect of fusion and orientation on 1,2,4-butanetriol production. Columns 
represent a single experiment. 
  As a first test of enzyme colocalization, fusions between enzymes two and 
three, YjhG and MdlC, using a single L16 linker, were constructed in both 
orientations. The same was done for enzymes three and four, MdlC and AdhP. When 
coexpressed with the other free enzymes in the pathway, only two of the four fusions 
gave detectable levels of 1,2,4-BT production, and neither showed improvements over 
the free enzymes (Figure 3.15). Given that YjhG appeared intolerable to fusion, this 
approach was abandoned in lieu of pursuing PIDs.  
 For simplicity, a single PID pair was chosen for testing, cJun-cFos, since it 
performed similarly to GCN4, and formed only heterodimers. Additionally, since 
competing reactions are only well defined for the second intermediate, these PIDs 
were formed only between enzymes YjhG and MdlC. As shown in Figure 3.16, these 
PIDs reduced the levels of 1,2,4,-BT over the free enzyme control. 
Discussion 
Despite the promise of enzyme colocalization from the large number of 
successful in vitro studies, their intentional and successful engineering has proven 
much more challenging. Synthetic metabolic pathways suffer from a number of 
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Figure 3.16. Effect of PIDs on 1,2,4-butanetriol production. Columns represent a 
single experiment. 
limitations that curb engineering efforts towards this aim. (1) Proteins from 
heterologous hosts commonly suffer from low expression and poor folding properties 
in their new environment. (2) If they indeed fold, many, if not most, metabolic 
enzymes are multimeric in structure [104], which can lead to an assembly conundrum 
during colocalization and impairs activity. (3) If the proteins fold and are active, 
synthetic pathways have not been evolved to balance rates, and these flux imbalances 
offset the benefits that may result from enzyme colocalization. For example, the 
catalytic activity for DkgA is 10-fold below that of MgsA [115,116]. When 
considering this, it is no surprise that the greatest in vivo success resulted from an 
evolved, rather than designed system [8].  
In order to address these issues, we set out to test the large set of parameters 
for colocalized enzymes, both in terms of the mechanisms employed as well as the 
reaction-diffusion kinetics involved. Fusion proteins proved intractable to 
modification, and led to both reductions in solubility and in activity over the free 
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enzymes, even when they performed better than the appropriate control. The relatively 
few design choices here may ultimately limit the application of this technology. PIDs 
represent a great step forward for enzyme colocalization. Although their performance 
was similar, the possibility of using solubility enhancing binding domains with small 
ligands may enhance both individual and couple kinetic properties of the system. 
Further, the ability to toggle binding affinity may prove useful in allowing the 
sequential enzymes to colocalize and allow their activity to be unperturbed by 
termporarily dissociating. Ultimately, the challenge facing fusions and PIDs is the 
inability to balance flux in a robust manner. With fusion and PIDs, the ratios of the 
sequential catalytic centers is dictated by the multimerization state of the enzymes, and 
this may be true whether or not one coexpresses free enzymes to populate these 
structures. This fact limits these systems to improvements from only reduced 
diffusional times, since a flux imbalance would prevent intermediate sequestration. To 
address this issue, we employed a protein scaffold that would allow each enzyme to 
bind independently and thus their ratios could be toggled. Unfortunately here, a 
tripartite fusion of protein docking domains is not well suited for soluble and stable 
expression in E. coli. Since this system provides the maximum design parameters, 
developing a stable intracellular scaffold will be an important improvement, especially 
for systems greater than two or three enzymes.  
This study addressed two metabolic pathways, 1,2-PD and 1,2,4-BT, and this 
variety of enzymes, from three different hosts, begins to represent the diversity in 
engineering metabolic pathways. However, the diffusion properties of the 
intermediates are very similar for these pathways, with molecular weights all under 
200 Daltons. If indeed, the benefits are seen with much slower diffusivities [12], other 
metabolic pathways will have to be pursued to analyze this effect experimentally. 
Nevertheless, this study highlights the challenges in engineering enzyme 
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colocalization and stresses the need for modular strategies with high degrees of 
freedom in order to optimize around the metabolic pathway of interest. 
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CHAPTER 4 
 
REPROGRAMMING SYNTHETIC PATHWAYS IN BACTERIA USING 
ENGINEERED SCAFFOLDS  
Introduction 
The intentional engineering of metabolic pathways is a rapidly maturing field 
and much attention has already been given to cellular productivity and diverted flux. 
Indeed, a number of strategies have been reported for optimizing cellular metabolism 
including, for example, stabilizing mRNA transcript levels, balancing protein 
expression levels, evolving enzyme activity, and redirecting cellular metabolism [34]. 
Recently, an orthogonal strategy was developed for the intentional colocalization of 
metabolic enzymes along a synthetic intracellular scaffold for the production of both 
mevalonate and glucaric acid [58,59]. The authors reported a 77-fold improvement in 
mevalonate titers while maintaining very low enzyme levels, which served to reduce 
cell stress [58]. Due to the exceptionally low enzyme levels in this case, isolating the 
impact from changes in individual enzyme activity and protein levels were not 
possible [117]. In another study, despite high initial titers, glucaric acid levels 
increased 5-fold, due in large part to the substrate activation of the scaffolded MIOX 
enzyme, whose individual activity increased 18 to 49-fold [59]. This stands as the 
clearest case of locally increased intermediate concentrations, but this benefit cannot 
be extended towards all metabolic pathways. Nevertheless, these engineering 
metabolic pathways are remarkable examples of using the power of synthetic biology 
to mimic nature‘s synergy.  
These successes notwithstanding, protein scaffolds employed above begin to 
break down when considering large metabolic pathways or even a high number of 
repeating scaffold sites. The prospect of a stable, well expressed 11-domain fusion in 
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E. coli as employed [59] should stand at the limit of protein folding, and even if not, 
problems during plasmid construction of repeating DNA units [59], indicate a need for 
a new type of molecular scaffold. Further, despite the promising results, the difficulty 
in isolating the impact of enzyme stability, individual, and coupled activity, begs the 
need for a new type of scaffold that permits these controlled experiments in vivo. 
Here, we present a study of enzyme colocalization for the production of both 
1,2-propanediol and mevalonate from three enzymatic steps that branch from E. coli 
central carbon metabolism. Since bacterial production of 1,2-PD and mevalonate are 
hindered by the accumulation of the bactericidal intermediates and by the formation of 
undesired side products from competing pathways, these represents a unique 
opportunity for artificial enzyme compartmentalization as a means to increase 
production titers via the reduction of toxicity and side product formation. In this study 
we investigate the use of a stable and well-ordered biological scaffold for successive 
docking of our metabolic pathway enzymes. Using the available components within a 
bacterial cytoplasm, plasmid DNA is employed to provide an ordered surface for 
modification. The use of modular DNA binding domains permits enzyme 
colocalization along its surface and the subsequent optimization of metabolite 
production within these pathways. The techniques presented here provide a generic 
framework for creating colocalized enzymes and should be useful in evaluating the 
contribution of enzyme compartmentalization within any recombinant pathway of 
interest. 
Materials and methods 
1,2-PD biosynthesis pathway. Plasmids were constructed using molecular biology 
techniques according to standard practices [97]. The three sequential genes for 
encoding 1,2-PD biosynthesis, (1) mgsA, (2) dkgA, and (3) gldA were PCR amplified 
from E. coli MG1655 genomic DNA. These genes were then cloned into pBAD18 
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[98] in the order shown, using unique restriction sites within the multiple cloning site, 
resulting in a polycistron for 1,2-PD synthesis. The first gene was placed between 
NheI and XbaI, the second gene between XbaI and SphI, and the last gene between 
SphI and HindIII. The same strong ribosomal binding site was placed directly 
upstream of each gene in the polycistron and an NdeI site at each start codon. 
To the C-terminus of MgsA, the zinc finger triplet OZ052 (ZFa) [118] was codon 
optimized and fused by an L5 polylinker [64]. To the C-terminus of DkgA, the zinc 
finger triplet OZ300 (ZFb) [118] was codon optimized and fused by an L5 polylinker 
[64]. To the C-terminus of GldA, the zinc finger triplet OZ076 (ZFc) [118] was codon 
optimized and fused by an L5 polylinker [64]. Each zinc finger had a C-terminal HA 
epitope tag. 
Mevalonate biosynthetic pathway. Plasmids were constructed using molecular 
biology techniques according to standard practices [97]. The mevalonate pathway 
enzymes were tethered to zinc fingers, based on the construct pRM178 [58]. Here the 
linker and ligand at the 3‘ end of each gene was excised and replaced exactly with the 
L5 linker and appropriate zinc finger as above. ZFa was fused to AtoB, ZFb fused to 
HMGS, and ZFc fused to HMGR, with a C-terminal HA epitope HA on all proteins. 
The resulting plasmid was named, pRM178-ZF. 
DNA Scaffold Constructs. pUC19 [119] served as the basis for construction of the 
DNA scaffold. pUC19 was digested with AatII and PvuII and ligated with a polylinker 
containing the following restriction sites: AatII-SacI-SpeI-XbaI-SphI-ClaI-PvuII. The 
scaffold sequences were based on the following binding sites: (1) ZFa: 5‘-
GTCGATGCC-3‘, (2) ZFb: 5'-GCGGCTGGG-3', and (3) ZFc: OZ076 5'-
GAGGACGGC-3'. DNA scaffolds were assembled using SpeI and XbaI cohesive 
ends compatible ends for ligation. Basic parts were made so that they would be 
flanked by an SpeI site on the 5‘ end and XbaI site on the 3‘ end. Composite scaffolds 
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were constructed by digesting the backbone with XbaI and adding an SpeI/XbaI 
digested insert at the 3‘ end, maintaining the SpeI at the 3‘ end and XbaI site at the 5‘ 
end. To separate the binding sites, a 12 base pair spacer was employed for linear 
constructs and a 4 base pair spacer for spiral constructs. For 1,2-PD production, the 
resulting scaffold were (1) subcloned into pBAD18, between the B-lactamase and 
pBAD promoters, (2) subcloned into pZE11-MCS1 at the AatII/XbaI sites, or (3) used 
directly from pUC19. For mevalonate production, the scaffolds were employed 
directly from pUC19.  
Bacterial strains, media, and growth conditions. E. coli W3110 [F
−
 
−
 rph-1 
INV(rrnD, rrnE)] or its derivatives were used for 1,2-PD production unless otherwise 
noted. 1,2-PD fermentations were followed as described [82] with the following 
exceptions. L-arabinose was added to 0.2% (w/v) at the time of inoculation to induce 
gene expression. All fermentations were run at 37°C, either at 200 or 250 rpm, with 
tubes held vertically or at a 45 degree angle. The 10-mL fermentation mixtures were 
inoculated to an optical density of 0.05 (typically 1:50 to 1:100 dilution) with the 
overnight culture. The optical density (OD) was measured at 600 nm with a Thermo 
Spectronic BioMate 3 model spectrophotometer.  
Mevalonate production was followed as described [58]. Antibiotics were 
provided at the following concentrations: ampicillin, 100 μg/mL; chloramphenicol, 20 
μg/mL; spectinomycin, 20 ug/mL. 
HPLC analysis. Products in the fermentation media were quantified as described [82] 
with the following exceptions. Compounds were measured with a Waters Breeze 
system. The mobile phase was a 0.03 N sulfuric acid solution, with a flow rate of 0.45 
ml per min, and the column temperature was 50°C. All samples were filtered through 
0.22-μm-pore-size membranes prior to analysis. 
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Protein purification. Maltose binding protein was PCR amplified from E. coli 
MG1665 genomic DNA and cloned into pET28a(+) (Invitrogen). The 3‘ end was 
appended with a codon optimized L5 linker along with the appropriate zinc finger with 
or without epitope tags. Growth and purification were followed as described [120] 
with the following exceptions. Cell cultures were induced with 0.3 mM IPTG for 3 
hours. Cell lysates were applied over amylose resin (NEB) using Poly-Prep 
Chromatopgraphy Columns (Bio-Rad) with WB1 buffer substituted for column 
buffers. Elutions were collected in fractions and the concentrations were estimated by 
absorbance at 280 nm. 
Electrophoretic mobility shift assay. DNA oligos were 5‘ biotinylated (IDT) and 
annealed by slow cooling from 95 C. Binding assays were performed as described 
[120]. Complexes were run on 5% TBE-PAGE gels (Bio-Rad) at 4 C. Samples were 
transferred to Biodyne B Nylon Membranes (Pierce). Detection was performed using a 
LightShift Chemiluminescent EMSA Kit (Pierce). 
Western blot analysis. W3110 cultures were grown overnight in LB media, 
inoculated as above, lysed via sonication after either 9 or 24 hours, and normalized on 
the amount of total soluble cell protein, with 0.2 ug total loaded in each lane. Insoluble 
lysates were isolated by centrifugation at 16,000 g for 10 minutes. Pellets were washed 
twice with 1 mL of with Tris-Cl (50 mM) and EDTA (1 mM) pH 8.0. The pellet is 
then resuspended in 1x PBS and 2% SDS and then boiled for 10 minutes. The 
insoluble fraction is collected as the supernatant following a 10 minute centrifugation 
at 16,000 g. Western
 
blotting of these soluble and insoluble lysates was performed 
with anti-HA primary antibody (1:1000, v/v; Sigma) and anti-rabbit secondary 
antibody (1:2500, v/v; Promega) on SDS-PAGE gels, typically 10 or 12%. 
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Figure 4.1. (A) Metabolic pathway of 1,2-PD production from dihydroxyacetone 
phosphate in E. coli. (B) Example of enzyme architecture along a plasmid DNA 
surface. Arrows indicate direction of reaction progress. 
Results 
Independent control of enzyme colocalization. A biosynthetic route towards 1,2-PD 
has been well defined ([82], and Chapter 3 above, and Figure 4.1A), and the 
compartmentalization of these three enzymes would enable sequestration of the toxic  
methylglyoxal intermediate [3], reduce diverted flux, and balance pathway flux. In 
order to create a modular and stable scaffold, capable of a wide array of defined 
geometries, we envisioned the use of a plasmid DNA scaffold surface to which 
successive enzymes could dock to form an efficient reaction sequence (Figure 4.1B). 
Control of enzyme position on the DNA surface was gained through the use of 
engineered zinc finger triplets [118], which have been developed for a large number of 
specific 9 base pair DNA sites. By simply fusing these to the C-terminal domain of 
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our metabolic enzymes, we could successively target each enzyme to a specific site on 
a plasmid molecule. In a relatively short distance, the series of enzymes could be 
spatially arranged along the DNA molecule (Figure 4.1B). In this manner, enzyme 
stoichiometry and spacing was determined through regular placement of these scaffold 
sites along the DNA molecule (Figure 4.1B). Individual control over the proteins and 
scaffolds are maintained by transcriptional control of protein levels, and by varying 
the plasmid origin of replication and numbers of repeating units to control DNA 
scaffold levels. 
 As a first test of the system components, it was important to quantify the 
binding affinities of the zinc finger-DNA complexes to determine how these parts 
would function in vivo. A gel shift assay, employing an MBP fusion was used to 
assess the dissociation constant of zinc finger triplets for short linear dsDNA. The first 
triplet tested, here ZFa, bound with a KD in the low nM range, and further showed that 
the presence of an epitope tag would not dramatically hinder this interaction (Figure 
4.2A). This finding is significant because comparison of intracellular protein levels is 
important in determining if enzyme channeling is present [117]. Testing other 
engineered triplets towards orthogonal DNA sites, the dissociation constant was found 
to be similarly in the low nM range. This may be a general feature of zinc finger 
triplets, engineered through in vivo selections [118] that may well permit their general 
use in expanding colocalized metabolic pathways.  
Extending these results in vivo, we selected a small number of enzyme 
stoichiometries that had been previously successful [58], and were determined to be 
useful in balancing the flux given that the catalytic activity of MgsA is much greater 
than that of DkgA [115,116]. Given the well-defined local structure of plasmid DNA, 
it was necessary to identify possible enzyme arrangements on the scaffold surface. The 
motivation to employ bidirectional scaffolds is derived from the fact that plasmid  
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Figure 4.2. EMSA of MBP-zinc finger fusions and their biotinylated-DNA target. (A) 
Effect of epitope tag on dissociation constant of zinc finger A-DNA interaction and 
(B) Effect of various zinc fingers on the dissociation constant of zinc finger-DNA 
interaction. Detection with streptavidin-HRP against biotinylated DNA. 
DNA copy numbers [121] are commonly far below that of overexpressed metabolic 
enzymes. With this in mind, a simple scaffold geometry, like the one shown in Figure 
4.1B, could need to be repeated tens of times on a plasmid to achieve full site 
occupancy, so scaffold sites were designed to be compatible in this context.  
DNA scaffolds increase 1,2-PD levels with precise control. 1,2-PD titers were 
measured when no scaffold sites were present on the plasmid DNA and fold 
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Figure 4.3. Fold improvement in 1,2-PD production comparing various linear DNA 
scaffold stoichiometries and numbers of repeats to the case where no DNA scaffold is 
present. The scaffold stoichiometries have the following geometries: 1:1:1 as (ABC)n, 
1:2:1 as (BABC)n, 1:2:2 as (CBABC)n, 1:4:1 as (BBABC)n, 1:4:2 as (CBBABBC)n, 
where A represents MgsA binding; B, DkgA binding; C, GldA binding; and n is the 
number of repeats of the defined unit. Columns represent the average of three 
experiments with standard error of less than 30 percent. 
improvement was determined for each scaffold stoichiometry and number of repeating 
units against this control. A 4.5-fold improvement is achieved for scaffold harboring 
both a 1:1:1 and 1:2:2 stoichiometry (Figure 4.3). Titers were highly dependent on 
both the stoichiometry of binding sites as well as the number of repeating units of 
these sites. For example, while 4-fold improvements were achieved with both a 1:1:1 
and a 1:4:2 scaffold, the titers for the 1:1:1 geometry is relatively independent of the 
number of repeating units, while the 1:4:2 scaffold shows a clear maximum, after 
which improvements drop off markedly. Four of the five scaffolds show maxima in 
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the numbers of repeats, akin to the optimal induction levels observed for protein 
scaffolds [58]. Here, the impact on the precise number of binding sites is more direct 
given the consistency of DNA levels observed (data not shown), where protein levels 
are harder to control since (1) few promoters show a linear response [121] and (2) 
aggregation and degradation rates depend on the amount of overexpressed protein. 
 To investigate the role of scaffold numbers for each pathway enzyme, we 
transformed Figure 4.3 into one that plots the fold improvements against the number 
of scaffold sites for each enzyme (Figure 4.4). Interestingly, each enzyme shows a 
maximum in 1,2-PD levels when plotted against the number of binding sites. This 
effect is most clear for DkgA although this trend may continue for MgsA and GldA if 
scaffold constructs were built that contained up to 64 binding. This is the logical 
outcome since there are several competing reactions for the methyglyoxal intermediate 
[104]. Important to note is that there is still a large variation between stoichiometries 
in the improvement towards 1,2-PD which suggests that enzyme stoichiometry plays 
an important role in increasing 1,2-PD titer. 
Role of protein levels and DNA site spacing on improvements to 1,2-PD. Enzyme 
levels were measured when no scaffold sites were present on the plasmid DNA and 
compared to those of a 1:2:1 scaffold stoichiometry with varying numbers of repeats. 
Enzyme levels for both MgsA and DkgA are highly dependent on both the presence 
and number of repeating scaffold units (Figure 4.5). Surprisingly, the plasmid with a 
single MgsA binding site results in a 13-fold increase in its protein level, which is 
relatively constant until the number of binding sites increases to 8 or 16. The same 
trend is true for DkgA as well, though less dramatic, and the presence of DkgA 
binding sites increases its protein level up to 5-fold. Surprisingly, the simple act of 
binding to DNA does not drive this increase in protein levels, as fewer binding sites  
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Figure 4.4. Fold improvement in 1,2-PD production for various numbers of DNA 
scaffold sites for each enzyme, compared to where no DNA scaffold is present.  
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1 2 164 8 # of Repeats 
Linear (1:2:1) Scaffold Geometry
(-)
DkgA-ZFb-HA
MgsA-ZFa-HA
Anti-HA
3.2 3.7 1.34.5 2.01.0 DkgA Protein Levels
13.0 12.6 4.914.5 6.81.0 MgsA Protein Levels
3.2 3.2 2.43.9 3.51.0 1,2-PD Levels  
Figure 4.5. Western Blot of soluble protein levels of both MgsA and DkgA with no 
scaffold or varying repeats of the 1:2:1 scaffold geometry. Below, relative protein 
levels are presented (ImageJ, NIH), along with relative 1,2-PD production levels from 
Figure 4.3.  
results in higher protein levels. It may be that a tightly packed scaffold may cause an 
increase in stability whereas this effect disappears when proteins sparsely populate the 
DNA surface. Additionally, the increase in protein levels, especially for DkgA, trends 
with the increase in 1,2-PD titers, an effect not seen for protein scaffolds and glucaric 
acid production [59]. As a result, further experiments to decouple binding from 
enzyme proximity will be especially important to determine the role of enzyme 
colocalization. 
 As a further investigation into the improvement of scaffolding enzymes, DNA 
binding sites were constructed with a varying geometry. Instead of the linear enzyme 
format shown in Figure 4.1B, a shorter 4 base pair spacing between binding sites was 
employed so that each enzyme rotated 450 degrees around the plasmid DNA, instead 
of 720 degrees in a linear structure. Although the resulting spiral led to tighter site 
packing, the distance in space between enzymes remained similar. 1,2-PD titers were 
measured when no scaffold sites were present on the plasmid DNA and fold 
improvement was determined for each scaffold stoichiometry and number of repeating 
units against this control. Here, a 4.0-fold improvement is achieved for scaffold  
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Figure 4.6. Fold improvement in 1,2-PD production comparing various spiral DNA 
scaffold stoichiometries and numbers of repeats to the case where no DNA scaffold is 
present. The scaffold stoichiometries have the following geometries: 1:1:1 as (ABC)n, 
1:2:1 as (ABCB)n, 1:2:2 as (ABCCB)n, 1:4:1 as (ABCBB)n, 1:4:2 as (ABBCCBB)n, 
where A represents MgsA binding; B, DkgA binding; C, GldA binding; and n is the 
number of repeats of the defined unit. Columns represent the average of three 
experiments with standard error of less than 55 percent. 
harboring a 1:1:1 stoichiometry and other scaffolds showing much less improvement 
(Figure 4.6). Interestingly, the spiral scaffolds all performed the same or worse than 
the linear scaffold counterpart, implying that the enzyme geometry does matter. Even 
though this alternative arrangement did not perform as well, it suggests that the 
geometry of DNA binding sites is an important parameter that should be considered 
when engineering a metabolic pathway. 
1,2-PD improvements are binding dependent. To demonstrate that the 
improvements in 1,2-PD titers results from enzyme docking and not simply the  
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Figure 4.7. Fold improvement in 1,2-PD production comparing no scaffold to a 1:2:1 
scaffold with two repeats to the same scaffold harboring point mutations. Columns 
represent the average of three experiments with standard error of less than 4 percent 
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Figure 4.8. Western Blot of soluble protein levels on samples of Figure 4.7. 
presence of the DNA scaffold sequence, point mutations were made to the 1:2:1-2x 
scaffold sequence to reduce the binding affinity for the zinc finger triplets. It is 
important to note that no changes were made to the proteins themselves and fewerthan 
10% of the base pairs were mutated over the original scaffold. When tested for the 
production of 1,2-PD, the scaffold harboring point mutations led to a 40% reduction in 
1,2-PD levels (Figure 4.7), while maintaining similar protein levels (Figure 4.8). 
Surprisingly, the scaffold with the point mutation still led to the same high protein 
levels, while experiencing somewhat lower 1,2-PD levels. This suggests that the full 
synergy is retained only when enzymes have high affinity for the scaffold sites, though 
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even low binding affinity for the DNA is sufficient to increase protein levels compared 
to having no scaffold present. This is possible because the zinc fingers likely retained 
some affinity for the mutated sites and because nM affinity is not required when 
protein concentrations inside the cell greatly exceed that amount. 
DNA scaffold benefits generalizable to mevalonate biosynthetic pathway. 
Mevalonate titers were measured when no scaffold sites were present on a separate 
plasmid DNA and fold improvement was determined for each scaffold stoichiometry 
and number of repeating units against this control. A 3.9-fold improvement is 
achieved for scaffold harboring a 1:4:2 (Figure 4.9). Titers were highly dependent on 
both the stoichiometry of binding sites as well as the number of repeating units of 
these sites. For example, the 1:2:1 stoichiometry has increasing yields with the number 
of repeats while the reverse is true for the 1:2:2 and 1:4:2 stoichiometries. 
Interestingly, the 1:4:1 stoichiometry was the worst performing arrangement, which is 
consistent with the second intermediate being cytotoxic [58]. The fact that the 1:2:2 
ratio performed best using protein scaffolds is not surprising given the differences in 
site ordering, enzyme expression levels, and differences in the numbers of binding 
sites used here. The fact that similar improvements were achieved for mevalonate as 
1,2-PD suggests that DNA scaffolds may be generalizable to increasing metabolite 
yields for a variety of synthetic pathways. 
Discussion 
While engineers have not yet realized the promise of enzyme compartmentalization in 
the form of a protected tunnel [10] or intracellular organelles [122], the use of DNA 
scaffolds is an important extension from the protein scaffolds developed for both 
mevalonate and glucaric acid production [58,59]. The ultra stable nature of DNA and 
its ability to permit long range scaffolds, here up to 2.4kb with over 100 individual 
binding sites, will enable the colocalization of large metabolic pathways where it will  
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Figure 4.9. Fold improvement in mevalonate comparing various linear DNA scaffold 
stoichiometries and numbers of repeats to the case where no DNA scaffold is present. 
The scaffold stoichiometries have the following geometries: 1:1:1 as (ABC)n, 1:2:1 as 
(ABCB)n, 1:2:2 as (ABCCB)n, 1:4:1 as (ABCBB)n, 1:4:2 as (ABBCCBB)n, where A 
represents AtoB binding; B, HMGS binding; C, HMGR binding; and n is the number 
of repeats of the defined unit. Columns represent a single experiment. 
be important to create channels of more than three enzymes; a feat simply infeasible 
with protein scaffolds. Further, although the benefits of engineered metabolic channels 
exists with some controversy [123], DNA scaffolds permit the kind of controls 
necessary to assess these improvements in their natural environment. One can 
decouple binding from activity from synergy, and determine the role of each enzyme, 
all without making changes to the enzymes themselves or affecting the stability of the 
DNA scaffold itself. Finally, the binding to DNA scaffolds improves the levels of the 
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metabolic enzymes, not observed with protein scaffolds [59], which may itself be a 
useful tool in metabolic engineering. 
The DNA scaffolds presented here are not without drawbacks. First, the very 
rigidity of the DNA scaffold over short ranges could emphasize this. Since many 
metabolic enzymes are multimers, here MgsA6 and GldA8 for 1,2-PD and AtoB4, 
HMGS2, and HMGR2 for mevalonate, the flexibility of a protein scaffold may benefit 
by allowing the enzyme to form in their multimeric state on the same scaffold 
molecule. While this would be possible on DNA scaffold with the use of long peptide 
linkers connecting the enzymes to the zinc finger binding domains, this could offset 
the stability of these fusions. Second is that like with the protein scaffold, these zinc 
fingers impact native enzyme activity. Despite the larger size of these zinc finger 
triplets when compared to these peptide ligands, 100 versus 20 amino acids, both 
fusions have similar impact, implying this may be a general feature of enzyme 
activity. Similar to the studies of fusion and PID orientation in Chapter 3, however, 
this degree of freedom is retained with zinc finger triplets and may improve the 
individual enzyme activity back to its native levels. If the fold improvements from 
docking pathway enzymes are retained, real gains in metabolite levels could be 
observed.  
It is interesting that 1,2-PD levels were at the highest with a 1:1:1 
stoichiometry, keeping in mind the imbalances in catalytic activity of MgsA and 
DkgA. This result is complicated by the fact that GldA has catalytic activity towards 
methylglyoxal. In the 1:1:1 scaffold construct alone, repeating units juxtapose binding 
sites for MgsA and GldA, ABCABC as an example of two repeats. For this reason, 
this was avoided in the other stoichiometries.  
DNA scaffolds should prove a useful tool for synthetic biologists and 
metabolic engineers resulting from their stability, modularity, and ease of 
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implementation given the library of constructs that we have assembled. DNA scaffold 
offer a very high degree of freedom and parameters to consider are: site spacing, 
number, geometry, location on the plasmid, origin of replication, and binding affinity 
for the DNA-zinc finger complex. These parameters increase dramatically once 
changes to the enzyme fusion are considered and complete optimization of a system 
should permit very high titers. Important in all of this is that this approach is 
complementary to the well-developed tools of directed evolution and strain 
engineering commonly applied to metabolic pathways. A successful strategy will 
likely apply enzyme colocalization to a previously optimized system as preferential 
stoichiometries will likely vary with enzyme activity and cellular metabolite levels. Of 
particular interest may be that Zn
2+
 is required for zinc finger binding to DNA sites, 
and while not tested here, could be a useful on/off switch for coupled metabolic 
reactions. Considering the demonstrated improvements using DNA scaffolds and its 
vast promising from unexplored parameters, DNA scaffolds should provide a useful 
platform for engineering metabolite production in vivo. 
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CHAPTER 5 
 
A GENERAL STRATEGY FOR ENGINEERING ENZYME COLOCALIZATION 
 
A genenral strategy 
 The field of enzyme colocalization is ever growing [96] and recent results by 
ourselves and others [58,59] have begun to fulfill the promise of this nascent 
technology. While initial demonstrations were limited to in vitro settings, numerous 
mechanisms for colocalizing enzymes in vivo have been developed: fusions [40], post-
translational interactions (Chapter 3), protein scaffolds [58], and DNA scaffolds 
(Chapter 4). The development of these techniques has provided engineers with 
increasingly greater control over these systems and greater confidence that the 
synergistic benefits are real. In particular, the use of DNA scaffolds offers great 
potential to maximize metabolite production from couple enzymatic reactions with its 
ability to independently colocalize large metabolic pathways on a stable intracellular 
scaffold. Since the DNA scaffolding technology is limited to the bacterial cytoplasm, 
the concurrent development of other methods is important.  
 The persistence in nature of colocalized enzyme systems [68], once evolved, 
demonstrates the powerful driving forces for their occurrence: (1) decrease the 
intermediate transit time and to increase the catalytic efficiency that results from a net 
decrease in the Km value for channeled substrates, (2) reduce the cellular levels of 
intermediates while keeping the effective local substrate concentrations high, (3) swift 
conversion of toxic or unstable intermediates, (4) prevent inhibitory compounds from 
accessing and deactivating the active site, (5) prevent metabolic cross talk between 
competing pathways, (6) rapid and reversible assembly and disassembly allows for 
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differential control over the synthesis of secondary products in response to the intra- 
and extracellular environment [68]. When engineering cellular metabolism, these are 
the shortcomings that we can hope to overcome, and should look to when considering 
engineering enzyme colocalization. Metabolic pathways that suffer from slow 
substrate uptake, are cofactor limited [44], or have product toxicity [124], will likely 
not benefit from enhanced pathway synergy.  
When considering implementing DNA scaffolds, first one must select two or 
more sequential reactions to couple where the second reaction is limited by one of the 
aforementioned problems. All things being equal, this should come at the beginning of 
the synthetic metabolic pathway to maximize flux towards the end product of interest. 
An example of this is demonstrated in Chapter 3. Methylglyoxal suffers from several 
competing reactions and a flux imbalance, whereas acetol has no defined competing 
reactions, and the activity of GldA towards it is unknown. The next most critical 
feature is the impact of the zinc finger binding domain on native protein activity. The 
challenge observed thus far is that the deleterious modifications needed to colocalize 
enzymes outweigh the noted improvement from the couple reaction synergy (Chapter 
4). As seen with many protein fusions [40,125], while it is possible to impact novel 
activity (here, binding) often this comes at the expense of catalytic activity and 
folding. This situation is no different. As observed in Chapters 3 and 4, domain 
fusions significantly impact the metabolic enzymes involved in 1,2-PD and 1,2,4-BT 
production, so much so that 1,2,4-BT production was unable to be measured using 
DNA scaffolds because the fusion of zinc finger triplets eliminated native enzyme 
activity. However, the basic techniques demonstrated here of optimizing linker and 
orientation (Chapter 3), as well as other developed methods for engineering better 
folded proteins [126,127], can help to overcome this fundamental limitation. 
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After engineering the metabolic enzymes, it is time to consider the myriad of 
parameters governing the effectiveness of the DNA scaffold. The most important of 
which is likely the balance between the number of DNA binding sites and the number 
of enzymes that will bind. A simple assay will help will to approximate this value, for 
a single scaffold geometry, vary the number of repeats on a given plasmid to 
determine which gives the optimum metabolite levels. In more detail, intracellular 
protein levels can be compared to a dilution series of a purified sample by Western 
Blot and plasmid DNA levels can be similarly quantified by RT-PCR or by plasmid 
miniprep, after determining the cell concentration (cfu/mL). When the number of 
DNA binding sites is off by more than an order of magnitude, it is best to vary the 
plasmid copy number to adjust the number of binding sites. For small changes in the 
number of DNA binding sites, simply increasing or decreasing the numbers of 
repeating units will suffice. Further optimization of the scaffolds themselves, includes 
parameters such as: (1) site stoichiometry, (2) site ordering, e.g. ABBCC vs. CBABC, 
(3) site spacing along the DNA, (4) interaction strength of the DNA-zinc finger 
complex, (5) site location on the plasmid. Many of these parameters have not been 
explored (Chapter 4) and the importance of each cannot be ascribed. Given the many 
degrees of freedom granted to the engineer, this should become a powerful technique 
for engineering metabolic pathway.  
Future work 
While the use of DNA scaffolds has been very successful in increasing 
metabolite production, the understanding behind the working of these systems is 
lacking. This stems from the challenges associated with multimeric enzymes and the 
difficulty in carefully balancing all of the components in these systems, even if all of 
the proper controls have been considered. Simulations of enzyme colocalization have 
been useful in furthering the theoretical understanding [12], but a gap between what is 
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being simulated and the actual system in vivo, and slow computational times, hinder 
the study of successful cases in vivo. In this way, in vitro assays could be instrumental 
in decoupling the effects of binding, activity, and synergy observed in vivo. The ability 
to measure individual enzyme activity, with and without fusion to zinc fingers, and 
with and without DNA binding will be important. The multimeric state of these 
complexes could be assessed by chromatography to determine (1) to what extent 
multiple DNA molecules are involved in the same enzyme complex and (2) if DNA 
binding prevents full complex formation. It would further be possible to study a 
variety of DNA scaffolds, enzyme stoichiometries, and flux balanced or imbalanced 
scenarios to determine when enzyme colocalization is most beneficial. This is turn will 
be very useful for the metabolic engineer in guiding future design of these systems and 
in envisioning new techniques for enzyme colocalization. 
These challenges notwithstanding, there are untapped opportunities for enzyme 
colocalization moving beyond the channeling of small molecules. As our simulations 
have demonstrated [12], the impact of enzyme compartmentalization is greatest for 
slow diffusing molecules, such as proteins. As proteins serve as metabolic 
intermediate in pathways of post-translational modification, including protein folding, 
the ability to reduce diffusional limitations could have an enormous impact. Of 
particular interest are pathways for proper disulfide bond formation and glycan 
formation for protein glycosylation. Challenges exist for both as disulfide bond 
formation would need to employ an oxidizing cytoplasm, such as exists in E. coli 
Shuffle (NEB), and glycan formation may need to employ a membrane binding motif, 
to localize the DNA where the reactions occur. However, these illustrate the enormous 
potential for enzyme colocalization as engineers begin to consider the benefits from 
coupled enzyme kinetics and further refinement in the techniques allows for greater 
ease of implementation. 
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APPENDIX  
 
Table A.1. Kinetic Rate Expressions 
Rate expressions used in this study were borrowed from Reuss [87]. Additional rate 
equations used in this work are listed below. 
 
rTCA1
kcatTCA1ETCA1COAACAcCoA
(KTCA1,oaa COAA)(KTCA1,accoa CAcCoA)
 
rISCDH
kcatISCDHEISCDHCISCCNAD
(KISCDH,isc CISC)(KISCDH,nad CNAD)
 
raKGDH
kcataKGDHEaKGDHCaKGCNAD
(KaKGDH,oaa CaKG)(KaKGDH,accoa CNAD)
 
rSucCoAS
kcatSucCoASESucCoASCSucCoACADP
(KSucCoAS,succoa CSucCoA)(KSucCoAS,adp CADP)
 
rSUCDH
kcatSUCDHESUCDHCSUCCCFAD
(KSUCDH,succ CSUCC)(KSUCDH,fad CFAD)
 
rFMase
kcatFMaseEFMaseCFUM
(KFMase,fum CFUM)
 
rMALDH
kcatMALDHEMALDHCMALCNAD
(KMALDH,mal CMAL)(KMALDH,nad CNAD)
 
rMAE
kcatMAEEMAECMAL
(KMAE,mal CMAL)
 
rCFSynth
kcatCFSynthECFSynthCISC
(KCFSynth,isc CISC)
 
rAASynth
kcatAASynthEAASynthCaKG
(KAASynth,aKG CaKG)
 
rAASynth2
kcatAASynth2EAASynth2COAA
(KAASynth2,oaa COAA)
 
rAASynth3
kcatAASynth3EAASynth3CAcCoA
(KAASynth3,accoa CAcCoA)
 
rCI1,f
kcatCI1ECI1
CNADPCNADH
KCI1,eq
(KCI1,nad(1
CNADH
KCI1,nadh
) CNAD)(KCI1,nadph(1
CNADP
KCI1,nadp
) CNADPH)
 
rCI1,r
kcatCI1ECI1CNADPHCNAD
(KCI1,nad(1
CNADH
KCI1,nadh
) CNAD)(KCI1,nadph(1
CNADP
KCI1,nadp
) CNADPH)
 
rOxPhos1
kcatOxPhos1EOxPhos1CNADHCADP
(KOxPhos1,nadh CNADH)(KOxPhos1,adp CADP)
 
rOxPhos2
kcatOxPhos2EOxPhos2CFADH2CADP
(KOxPhos2,fadh2 CFADH2 )(KOxPhos2,adp CADP)
 
rCI2
kcatCI2ECI2CATP
(KCI2,atp CATP)
 
rCI3
kcatCI 3ECI3CATPCAMP
(KCI 3,atp CATP)(KCI3,amp CAMP)
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rAC
kcatACEACCATP
(KAC,atp CATP)
 
rNADPHcons
kcatNADPHconsENADPHconsCNADPH
(KNADPHcons,nadph CNADPH)
 
rNADHcons
kcatNADHconsENADHconsCNADH
(KNADHcons,nadh CNADH)
 
rFADH2cons
kcatFADH2consEFADH2consCFADH2
(KFADH2cons,fadh2 CFADH2)
 
rMGS
kcatMGSEMGSCDHAP
(KMGS,dhap CDHAP)
 
rDhaD
kcatDhaDEDhaDCMGCNADH
(KDhaD,mg CMG)(KDhaD,nadh CNADH)
 
rAdhI
kcatAdhIEAdhICR lacCNADH
(KAdhI,R lac CR lac)(KAdhI,nadh CNADH)
 
 
 
Table A.2. Kinetic parameters. 
 
Enzyme 
activities Parameters 
Parameter 
values 
TCA1 KcatTCA1 176.63 s
-1
 
 KTCA1,accoa 1 mM 
 KTCA1,oaa 1 mM 
ISCDH KcatISCDH 87.85 s
-1
 
 KISCDH,isc 1 mM 
 KISCDH,nad 0.2 mM 
aKGDH KcataKGDH 85.35 s
-1
 
 KaKGDH,aKG 1 mM 
 KaKGDH,nad 0.2 mM 
SucCoAS KcatSucCoAS 100.38 s
-1
 
 KSuCCoAS,succoa 1 mM 
 KSucCoAS,adp 0.2 mM 
SUCDH KcatSUCDH 150.24 s
-1
 
 KSUCDH,succ 1 mM 
 KSUCDH,fad 0.2 mM 
Fmase KcatFMase 75.12 s
-1
 
 KFMase,fum 1 mM 
MALDH KcatMALDH 76.55 s
-1
 
 KMALDH,mal 1 mM 
 KMALDH,nad 0.2 mM 
MAE KcatMAE 7.73 s
-1
 
 KMAE,mal 1 mM 
CFSynth KcatCFSynth 11.06 s
-1
 
 KCFSynth,isc 1 mM 
AASynth KcatAASynth 2.20 s
-1
 
 81 
 
 KAASynth,aKG 1 mM 
AASynth2 KcatAASynth2 6.63 s
-1
 
 KAASynth2,oaa 1 mM 
AASynth3 KcatAASynth3 23.20 s
-1
 
 KAASynth3,accoa 1 mM 
CI1 KcatCI1 1225.44 s
-1
 
 KCI1,nadh 0.2 mM 
 KCI1,nadph 0.2 mM 
 KCI1,eq 0.214 
 KCI1,nad 0.2 mM 
 KCI1,nadp 0.2 mM 
OxPhos KcatOxPhos 486.91 s
-1
 
 KOxPhos,nadh 0.2 mM 
 KOxPhos,adp 0.2 mM 
OxPhos2 KcatOxPhos2 162.30 s
-1
 
 KOxPhos2,fadh 0.2 mM 
 KOxPhos2,adp 0.2 mM 
CI2 KcatCI2 418.59 s
-1
 
 KCI2,atp 0.2 mM 
CI3 KcatCI3 70.05 s
-1
 
 KCI3,atp 0.2 mM 
 KCI3,amp 0.2 mM 
AC KcatAC 57.89 s
-1
 
 KAC,atp 0.2 mM 
 KAC,g6p,ss 3.48 mM 
NADPHcons KcatNADPHcons 326.64 s
-1
 
 KNADPHcons,nadph 0.2 mM 
NADHcons KcatNADHcons 397.93 s
-1
 
 KNADHcons,nadh 0.2 mM 
FADH2cons KcatFADH2cons 66.32 s
-1
 
 KFADH2cons,fadh2 0.2 mM 
MGS KcatMGS 220 s
-1
 
 KMGS,dhap 0.2 mM 
DHAD KcatDHAD 220 s
-1
 
 KDHAD,mgs 0.4 mM 
 KDHAD,nadh 0.2 mM 
ALDI KcatALDI 220 s
-1
 
 KALDI,R-lac 0.2 mM 
 KALDI,nadh 0.2 mM 
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